The O
differential O
diagnosis O
of O
early O
gastric Habitat_B
mucosa Habitat_I
- O
associated O
lymphoma O
: O
polymerase O
chain O
reaction O
and O
paraffin O
section O
immunophenotyping O
. O

The O
distinction O
between O
benign O
florid O
lymphoid O
hyperplasia O
and O
low O
- O
grade O
gastric Habitat_B
mucosal Habitat_I
- Habitat_I
associated Habitat_I
lymphoid Habitat_I
tissue Habitat_I
( O
MALT Habitat_B
) O
lymphoma O
may O
be O
a O
challenge O
. O

The O
presence O
of O
monoclonal Habitat_B
B Habitat_I
cells Habitat_I
in O
Helicobacter Bacteria_B
pylori Bacteria_I
- O
chronic O
active O
gastritis O
has O
suggested O
that O
polymerase O
chain O
reaction O
( O
PCR O
) O
data O
should O
be O
viewed O
with O
caution O
. O

We O
investigated O
the O
reliability O
of O
PCR O
versus O
immunophenotyping O
in O
diagnosing O
early O
gastric Habitat_B
MALT O
lymphoma O
. O

We O
studied O
1511 O
biopsies O
from O
eight O
patients Habitat_B
with Habitat_I
high Habitat_I
- Habitat_I
grade Habitat_I
primary Habitat_I
gastric Habitat_I
lymphoma Habitat_I
, O
25 O
with O
low O
- O
grade O
MALT Habitat_B
lymphoma O
, O
32 O
with O
atypical O
lymphoid O
infiltrates O
, O
and O
39 O
with O
Helicobacter Bacteria_B
pylori Bacteria_I
- O
chronic O
active O
gastritis O
. O

Paraffin O
sections O
from O
all O
cases O
were O
stained O
with O
antibodies O
to O
CD20 Habitat_B
, O
CD3 Habitat_B
, O
AE1 O
/ O
AE3 O
, O
kappa O
and O
lambda O
. O

PCR O
was O
performed O
on O
paraffin O
sections O
using O
the O
primer O
set O
VH O
- O
FR3 O
/ O
J O
( O
H O
) O
. O

Using O
histopathology O
as O
the O
gold O
standard O
in O
diagnosis O
, O
we O
confirmed O
monoclonality O
in O
22 O
of O
25 O
MALT Habitat_B
lymphomas O
( O
88 O
% O
) O
; O
a O
clonal O
band O
was O
found O
in O
38 O
% O
( O
15 O
of O
39 O
) O
of O
patients Habitat_B
with Habitat_I
chronic Habitat_I
active Habitat_I
gastritis Habitat_I
. O

An O
immunophenotype O
pattern O
with O
predominance O
of O
CD20 Habitat_B
- Habitat_I
positive Habitat_I
cells Habitat_I
in O
lymphocytic Habitat_B
infiltrates O
was O
associated O
with O
monoclonality O
in O
92 O
% O
of O
cases O
. O

The O
presence O
of O
an O
enlarged O
irregular O
mantle O
zone O
was O
found O
in O
both O
monoclonal O
and O
polyclonal O
areas O
. O

An O
equal O
prevalence O
of O
B O
and O
T Habitat_B
cells Habitat_I
in O
lymphocytic Habitat_B
infiltrates O
was O
associated O
with O
a O
polyclonal O
pattern O
in O
24 O
of O
31 O
cases O
( O
77 O
% O
) O
. O

Immunostaining O
of O
sIg O
( O
kappa O
and O
lambda O
) O
was O
difficult O
in O
paraffin O
sections O
and O
convincing O
proof O
of O
monoclonality O
was O
not O
obtained O
. O

Lymphoepithelial Habitat_B
lesions Habitat_I
were O
infrequent O
in O
gastric Habitat_B
biopsies O
and O
their O
presence O
was O
highlighted O
with O
keratin O
stains O
. O

Because O
monoclonal Habitat_B
B Habitat_I
cells Habitat_I
are O
observed O
in O
Helicobacter Bacteria_B
pylori Bacteria_I
- O
associated O
gastritis O
, O
the O
correct O
interpretation O
of O
clonality O
by O
PCR O
remains O
unclear O
. O

Paraffin O
section O
IHC O
using O
CD20 Habitat_B
and O
CD3 Habitat_B
is O
especially O
useful O
to O
confirm O
the O
diagnosis O
of O
gastric Habitat_B
MALT O
lymphoma O
. O

Evaluation O
of O
antibacterial O
activity O
of O
synthetic O
aliphatic O
and O
aromatic O
monoacylglycerols O
. O

The O
antibacterial O
activity O
of O
synthetic O
aliphatic O
and O
aromatic O
monoacylglycerols O
( O
MAGs O
) O
was O
studied O
against O
two O
human Habitat_B
pathogens O
: O
Staphylococcus Bacteria_B
aureus Bacteria_I
and O
Escherichia Bacteria_B
coli Bacteria_I
. O

The O
active O
compounds O
inhibited O
selectively O
S Bacteria_B
. Bacteria_I
aureus Bacteria_I
. O

The O
most O
active O
compounds O
amongst O
them O
were O
those O
with O
medium O
size O
aliphatic O
chain O
and O
aromatic O
MAGs O
with O
electron O
withdrawing O
substituents O
at O
the O
aryl O
ring O
. O

The O
introduction O
of O
one O
or O
two O
- O
carbon O
spacer O
between O
the O
aryl O
ring O
and O
the O
carboxylic O
function O
did O
not O
influence O
antibacterial O
effectiveness O
. O

Isolation O
, O
expression O
and O
characterization O
of O
a O
minor O
allergen O
from O
Penicillium Habitat_B
crustosum Habitat_I
. O

A O
ribosomal O
P1 O
protein O
, O
Pen O
b O
26 O
from O
Penicillium Habitat_B
brevicompactum Habitat_I
, O
was O
previously O
identified O
as O
a O
major O
allergen O
. O

A O
homolog O
protein O
was O
isolated O
and O
characterized O
from O
Penicillium Habitat_B
crustosum Habitat_I
which O
is O
not O
known O
to O
be O
allergenic O
mold O
. O

A O
cDNA O
library O
of O
P Habitat_B
. Habitat_I
  Habitat_I
crustosum Habitat_I
was O
constructed O
and O
screened O
using O
a O
probe O
based O
on O
the O
DNA O
sequence O
of O
Pen O
b O
26 O
. O

A O
positive O
clone O
was O
isolated O
, O
expressed O
in O
Escherichia Bacteria_B
coli Bacteria_I
, O
purified O
and O
characterized O
by O
comparing O
its O
immunological O
and O
physical O
properties O
to O
Pen O
b O
26 O
. O

It O
was O
designated O
as O
Pen O
cr O
26 O
and O
had O
a O
321 O
nt O
ORF O
corresponding O
to O
107 O
amino O
acids O
with O
a O
MW O
of O
11 O
  O
kDa O
. O

Pen O
cr O
26 O
had O
strong O
sequence O
homology O
to O
Pen O
b O
26 O
( O
92 O
% O
for O
nucleotides O
and O
86 O
% O
for O
amino O
acids O
) O
and O
its O
physical O
and O
predicted O
structural O
properties O
were O
similar O
to O
the O
latter O
. O

The O
level O
of O
expression O
of O
Pen O
cr O
26 O
was O
much O
lower O
than O
that O
of O
Pen O
b O
26 O
in O
the O
same O
expression O
vector O
. O

Both O
proteins O
were O
recognized O
equally O
well O
by O
the O
IgG O
class O
specific O
antibodies O
, O
but O
Pen O
cr O
26 O
was O
poorly O
recognized O
by O
Penicillium Habitat_B
- Habitat_I
sensitive Habitat_I
atopic Habitat_I
sera Habitat_I
( O
IgE O
) O
, O
suggesting O
striking O
antigenic O
difference O
in O
IgE O
epitopes O
, O
i O
. O
e O
. O
, O
87 O
% O
were O
positive O
for O
Pen O
b O
26 O
while O
only O
23 O
% O
were O
positive O
for O
Pen O
cr O
26 O
. O

The O
allergenicity O
of O
Pen O
cr O
26 O
seems O
to O
be O
minor O
in O
nature O
and O
it O
could O
be O
a O
hypoallergenic O
variant O
of O
Pen O
b O
26 O
. O

Rickettsia Bacteria_B
infection O
in O
five O
areas O
of O
the O
state O
of O
São O
Paulo O
, O
Brazil O
. O

This O
study O
investigated O
rickettsial Bacteria_B
infection O
in O
animals Habitat_B
, O
humans Habitat_B
, O
ticks Habitat_B
, O
and O
fleas Habitat_B
collected O
in O
five O
areas O
of O
the O
state O
of O
São O
Paulo O
. O

Eight O
flea Habitat_B
species O
( O
Adoratopsylla Habitat_B
antiquorum Habitat_I
antiquorum Habitat_I
, O
Ctenocephalides Habitat_B
felis Habitat_I
felis Habitat_I
, O
Polygenis Habitat_B
atopus Habitat_I
, O
Polygenis Habitat_B
rimatus Habitat_I
, O
Polygenis Habitat_B
roberti Habitat_I
roberti Habitat_I
, O
Polygenis Habitat_B
tripus Habitat_I
, O
Rhopalopsyllus Habitat_B
lugubris Habitat_I
, O
and O
Rhopalopsyllus Habitat_B
lutzi Habitat_I
lutzi Habitat_I
) O
, O
and O
five O
tick Habitat_B
species O
( O
Amblyomma Habitat_B
aureolatum Habitat_I
, O
Amblyomma Habitat_B
cajennense Habitat_I
, O
Amblyomma Habitat_B
dubitatum Habitat_I
, O
Ixodes Habitat_B
loricatus Habitat_I
, O
and O
Rhipicephalus Habitat_B
sanguineus Habitat_I
) O
were O
collected O
from O
dogs Habitat_B
, O
cats Habitat_B
, O
and O
opossums Habitat_B
. O

Rickettsia Bacteria_B
felis Bacteria_I
was O
the O
only O
rickettsia Bacteria_B
found O
infecting O
fleas Habitat_B
, O
whereas O
Rickettsia Bacteria_B
bellii Bacteria_I
was O
the O
only O
agent O
infecting O
ticks Habitat_B
, O
but O
no O
animal Habitat_B
or O
human Habitat_B
blood Habitat_I
was O
shown O
to O
contain O
rickettsial Bacteria_B
DNA O
. O

Testing O
animal Habitat_B
and O
human Habitat_B
sera O
by O
indirect O
immunofluorescence O
assay O
against O
four O
rickettsia Bacteria_B
antigens O
( O
R Bacteria_B
. Bacteria_I
rickettsii Bacteria_I
, O
R Bacteria_B
. Bacteria_I
parkeri Bacteria_I
, O
R Bacteria_B
. Bacteria_I
felis Bacteria_I
, O
and O
R Bacteria_B
. Bacteria_I
bellii Bacteria_I
) O
, O
some O
opossum Habitat_B
, O
dog Habitat_B
, O
horse Habitat_B
, O
and O
human Habitat_B
sera O
reacted O
to O
R Bacteria_B
. Bacteria_I
rickettsii Bacteria_I
with O
titers O
at O
least O
four O
- O
fold O
higher O
than O
to O
the O
other O
three O
rickettsial Bacteria_B
antigens O
. O

These O
sera Habitat_B
were O
considered O
to O
have O
a O
predominant O
antibody O
response O
to O
R Bacteria_B
. Bacteria_I
rickettsii Bacteria_I
. O

Using O
the O
same O
criteria O
, O
opossum Habitat_B
, O
dog Habitat_B
, O
and O
horse Habitat_B
sera Habitat_I
showed O
predominant O
antibody O
response O
to O
R Bacteria_B
. Bacteria_I
parkeri Bacteria_I
or O
a O
very O
closely O
related O
genotype O
. O

Our O
serological O
results O
suggest O
that O
both O
R Bacteria_B
. Bacteria_I
rickettsii Bacteria_I
and O
R Bacteria_B
. Bacteria_I
parkeri Bacteria_I
infected O
animals Habitat_B
and O
/ O
or O
humans Habitat_B
in O
the O
studied O
areas O
. O

Iron O
transport O
in O
the O
genus O
Marinobacter Bacteria_B
. O

Marinobacter Bacteria_B
belong O
to O
the O
class O
of O
Gammaproteobacteria Bacteria_B
and O
these O
motile O
, O
halophilic O
or O
halotolerent O
bacteria O
are O
widely O
distributed O
throughout O
the O
world Habitat_B
' Habitat_I
s Habitat_I
oceans Habitat_I
having O
been O
isolated O
from O
a O
wide O
variety O
of O
marine Habitat_B
environments Habitat_I
. O

They O
have O
also O
been O
identified O
as O
members O
of O
the O
bacterial Habitat_B
flora Habitat_I
associated O
with O
other O
marine Habitat_B
organisms Habitat_I
. O

Here O
, O
using O
a O
combination O
of O
natural O
products O
chemistry O
and O
genomic O
analysis O
, O
we O
assess O
the O
nature O
of O
the O
siderophores O
produced O
by O
this O
genus O
and O
their O
potential O
relationship O
to O
phylogeny O
and O
lifestyle O
/ O
ecological O
niche O
of O
this O
diverse O
group O
of O
organisms O
. O

Our O
analysis O
shows O
a O
wide O
level O
of O
diversity O
in O
siderophore O
based O
iron O
uptake O
systems O
among O
this O
genus O
with O
three O
general O
strategies O
: O
( O
1 O
) O
production O
and O
utilization O
of O
native O
siderophores O
in O
addition O
to O
utilization O
of O
a O
variety O
of O
exogenous O
ones O
, O
( O
2 O
) O
production O
and O
utilization O
of O
native O
siderophores O
only O
, O
( O
3 O
) O
lack O
of O
siderophore O
production O
but O
utilization O
of O
exogenous O
ones O
. O

They O
all O
share O
the O
presence O
of O
at O
least O
one O
siderophore O
- O
independent O
iron O
uptake O
ABC O
transport O
systems O
of O
the O
FbpABC O
iron O
metal O
type O
and O
lack O
the O
ability O
for O
direct O
transport O
of O
ferrous O
iron O
. O

Siderophore O
production O
and O
utilization O
can O
be O
correlated O
with O
phylogeny O
and O
thus O
it O
forms O
a O
type O
of O
chemotaxonomic O
marker O
for O
this O
genus O
. O

Ampicillin O
- O
resistant O
Haemophilus Bacteria_B
influenzae Bacteria_I
type Bacteria_I
B Bacteria_I
possessing O
a O
TEM O
- O
type O
beta O
- O
lactamase O
but O
little O
permeability O
barrier O
to O
ampicillin O
. O

Ampicillin O
- O
resistant O
Haemophilus Bacteria_B
influenzae Bacteria_I
type Bacteria_I
B Bacteria_I
have O
been O
reported O
only O
during O
the O
past O
year O
. O

Five O
clinical Habitat_B
isolates O
from O
the O
U O
. O
S O
. O
and O
Germany O
all O
had O
the O
TEM O
- O
type O
beta O
- O
lactamase O
which O
is O
known O
to O
be O
transferred O
widely O
among O
other O
gram O
- O
negative O
bacilli O
. O

Unlike O
those O
bacilli O
, O
however O
, O
the O
H Bacteria_B
. Bacteria_I
influenzae Bacteria_I
cell O
had O
very O
little O
barrier O
to O
entry O
of O
penicillins O
. O

This O
greater O
permeability O
of O
the O
H Bacteria_B
. Bacteria_I
influenzae Bacteria_I
cell O
to O
penicillins O
appeared O
to O
reduce O
the O
protective O
effect O
of O
its O
beta O
- O
lactamase O
, O
in O
that O
acquisition O
of O
the O
TEM O
- O
type O
beta O
- O
lactamase O
increased O
levels O
of O
resistance O
to O
penicillins O
much O
less O
for O
individual O
cells O
of O
H Bacteria_B
. Bacteria_I
influenzae Bacteria_I
than O
for O
those O
of O
Escherichia Bacteria_B
coli Bacteria_I
. O

Large O
inocula O
of O
either O
species O
appeared O
highly O
resistant O
. O

The O
unusually O
low O
level O
of O
resistance O
of O
individual O
cells O
of O
H Bacteria_B
. Bacteria_I
influenzae Bacteria_I
containing O
the O
TEM O
- O
type O
beta O
- O
lactamase O
may O
have O
delayed O
their O
emergence O
or O
recognition O
, O
and O
has O
unresolved O
clinical O
implications O
. O

A O
novel O
receptor O
- O
ligand O
pathway O
for O
entry O
of O
Francisella Bacteria_B
tularensis Bacteria_I
in O
monocyte Habitat_B
- Habitat_I
like Habitat_I
THP Habitat_I
- Habitat_I
1 Habitat_I
cells Habitat_I
: O
interaction O
between O
surface O
nucleolin O
and O
bacterial O
elongation O
factor O
Tu O
. O

Francisella Bacteria_B
tularensis Bacteria_I
, O
the O
causative O
agent O
of O
tularemia O
, O
is O
one O
of O
the O
most O
infectious O
human Habitat_B
bacterial O
pathogens O
. O

It O
is O
phagocytosed O
by O
immune Habitat_B
cells Habitat_I
, O
such O
as O
monocytes Habitat_B
and O
macrophages Habitat_B
. O

The O
precise O
mechanisms O
that O
initiate O
bacterial O
uptake O
have O
not O
yet O
been O
elucidated O
. O

Participation O
of O
C3 O
, O
CR3 O
, O
class O
A O
scavenger O
receptors O
and O
mannose O
receptor O
in O
bacterial O
uptake O
have O
been O
already O
reported O
. O

However O
, O
contribution O
of O
an O
additional O
, O
as O
- O
yet O
- O
unidentified O
receptor O
for O
F Bacteria_B
. Bacteria_I
tularensis Bacteria_I
internalization O
has O
been O
suggested O
. O

We O
show O
here O
that O
cell Habitat_B
- O
surface O
expressed O
nucleolin O
is O
a O
receptor O
for O
Francisella Bacteria_B
tularensis Bacteria_I
Live Bacteria_I
Vaccine Bacteria_I
Strain Bacteria_I
( O
LVS Bacteria_B
) O
and O
promotes O
LVS Bacteria_B
binding O
and O
infection O
of O
human Habitat_B
monocyte Habitat_B
- Habitat_I
like Habitat_I
THP Habitat_I
- Habitat_I
1 Habitat_I
cells Habitat_I
. O

The O
HB O
- O
19 O
pseudopeptide O
that O
binds O
specifically O
carboxy O
- O
terminal O
RGG O
domain O
of O
nucleolin O
inhibits O
LVS Bacteria_B
binding O
and O
infection O
of O
monocyte Habitat_B
- Habitat_I
like Habitat_I
THP Habitat_I
- Habitat_I
1 Habitat_I
cells Habitat_I
. O

In O
a O
pull O
- O
down O
assay O
, O
elongation O
factor O
Tu O
( O
EF O
- O
Tu O
) O
, O
a O
GTP O
- O
binding O
protein O
involved O
in O
protein O
translation O
, O
usually O
found O
in O
cytoplasm O
, O
was O
recovered O
among O
LVS Bacteria_B
bacterial O
membrane O
proteins O
bound O
on O
RGG O
domain O
of O
nucleolin O
. O

A O
specific O
polyclonal O
murine Habitat_B
antibody O
was O
raised O
against O
recombinant O
LVS Bacteria_B
EF O
- O
Tu O
. O

By O
fluorescence O
and O
electron O
microscopy O
experiments O
, O
we O
found O
that O
a O
fraction O
of O
EF O
- O
Tu O
could O
be O
detected O
at O
the O
bacterial O
surface O
. O

Anti O
- O
EF O
- O
Tu O
antibodies O
reduced O
LVS Bacteria_B
binding O
to O
monocyte Habitat_B
- Habitat_I
like Habitat_I
THP Habitat_I
- Habitat_I
1 Habitat_I
cells Habitat_I
and O
impaired O
infection O
, O
even O
in O
absence O
of O
complement O
and O
complement O
receptors O
. O

Interaction O
between O
EF O
- O
Tu O
and O
nucleolin O
was O
illustrated O
by O
two O
different O
pull O
- O
down O
assays O
using O
recombinant O
EF O
- O
Tu O
proteins O
and O
either O
RGG O
domain O
of O
nucleolin O
or O
cell Habitat_B
solubilized O
nucleolin O
. O

Altogether O
, O
our O
results O
demonstrate O
that O
the O
interaction O
between O
surface O
nucleolin O
and O
its O
bacterial O
ligand O
EF O
- O
Tu O
plays O
an O
important O
role O
in O
Francisella Bacteria_B
tularensis Bacteria_I
adhesion O
and O
entry O
process O
and O
may O
therefore O
facilitate O
invasion O
of O
host Habitat_B
tissues Habitat_I
. O

Since O
phagosomal O
escape O
and O
intra O
- O
cytosolic O
multiplication O
of O
LVS Bacteria_B
in O
infected Habitat_B
monocytes Habitat_I
are O
very O
similar O
to O
those O
of O
human Habitat_B
pathogenic O
F Bacteria_B
. Bacteria_I
tularensis Bacteria_I
ssp Bacteria_I
tularensis Bacteria_I
, O
the O
mechanism O
of O
entry O
into O
monocyte Habitat_B
- Habitat_I
like Habitat_I
THP Habitat_I
- Habitat_I
1 Habitat_I
cells Habitat_I
, O
involving O
interaction O
between O
EF O
- O
Tu O
and O
nucleolin O
, O
might O
be O
similar O
in O
the O
two O
subspecies O
. O

Thus O
, O
the O
use O
of O
either O
nucleolin O
- O
specific O
pseudopeptide O
HB O
- O
19 O
or O
recombinant O
EF O
- O
Tu O
could O
provide O
attractive O
therapeutic O
approaches O
for O
modulating O
F Bacteria_B
. Bacteria_I
tularensis Bacteria_I
infection O
. O

New O
one O
- O
week O
, O
low O
- O
dose O
triple O
therapy O
for O
the O
treatment O
of O
duodenal Habitat_B
ulcer O
with O
Helicobacter Bacteria_B
pylori Bacteria_I
infection O
. O

Antimicrobial O
therapy O
is O
the O
recommended O
treatment O
for O
duodenal Habitat_B
ulcer Habitat_I
associated O
with O
Helicobacter Bacteria_B
pylori Bacteria_I
infection O
. O

The O
eradication O
of O
bismuth O
- O
based O
triple O
therapy O
with O
bismuth O
subcitrate O
, O
metronidazole O
and O
amoxicillin O
is O
limited O
by O
low O
compliance O
, O
drug O
resistance O
and O
side O
- O
effects O
. O

Two O
- O
week O
proton O
pump O
inhibitor O
( O
PPI O
) O
- O
based O
triple O
therapy O
has O
a O
higher O
eradication O
rate O
but O
is O
costly O
. O

This O
study O
was O
designed O
to O
compare O
the O
efficacy O
, O
patient Habitat_B
compliance O
and O
cost O
of O
short O
- O
term O
PPI O
- O
based O
triple O
therapy O
with O
those O
of O
bismuth O
- O
based O
triple O
therapy O
. O

Ninety O
patients Habitat_B
with Habitat_I
active Habitat_I
duodenal Habitat_I
ulcer Habitat_I
disease Habitat_I
and Habitat_I
H Habitat_I
pylori Habitat_I
infection Habitat_I
, O
proven O
with O
the O
13C O
- O
urea O
breath O
test O
and O
CLO O
test O
( O
Campylobacter Bacteria_B
- O
like O
organism O
test O
) O
were O
treated O
randomly O
in O
three O
therapeutic O
groups O
: O
Group O
A O
, O
DeNol O
120 O
mg O
, O
amoxicillin O
500 O
mg O
and O
metronidazole O
250 O
mg O
four O
times O
a O
day O
orally O
for O
14 O
days O
; O
Group O
B O
, O
omeprazole O
20 O
mg O
plus O
clarithromycin O
500 O
mg O
twice O
a O
day O
and O
amoxicillin O
500 O
mg O
four O
times O
a O
day O
for O
14 O
days O
; O
Group O
C O
, O
omeprazole O
20 O
mg O
, O
clarithromycin O
250 O
mg O
and O
metronidazole O
500 O
mg O
twice O
a O
day O
for O
seven O
days O
. O

Nizatidine O
150 O
mg O
twice O
a O
day O
was O
given O
continuously O
following O
the O
end O
of O
anti O
- O
H Bacteria_B
pylori Bacteria_I
therapy O
for O
each O
group O
. O

Two O
months O
later O
, O
endoscopy O
, O
the O
CLO O
test O
and O
13C O
- O
urea O
breath O
test O
were O
repeated O
to O
assess O
the O
eradication O
rate O
of O
H Bacteria_B
pylori Bacteria_I
and O
the O
ulcer Habitat_B
- O
healing O
rate O
. O

Drug O
tolerance O
was O
evaluated O
by O
patients Habitat_B
themselves O
by O
daily O
recording O
of O
any O
side O
- O
effects O
. O

Eighty O
- O
four O
patients Habitat_B
completed O
the O
entire O
course O
of O
therapy O
and O
evaluation O
for O
H Bacteria_B
pylori Bacteria_I
infection O
. O

The O
H Bacteria_B
pylori Bacteria_I
eradication O
rates O
in O
Groups O
A O
, O
B O
and O
C O
were O
75 O
% O
( O
21 O
/ O
28 O
) O
, O
93 O
% O
( O
26 O
/ O
28 O
) O
and O
89 O
% O
( O
25 O
/ O
28 O
) O
, O
respectively O
( O
p O
= O
0 O
. O
466 O
) O
. O

The O
ulcer Habitat_B
healing O
rate O
was O
86 O
% O
( O
24 O
/ O
28 O
) O
in O
Group O
A O
and O
89 O
% O
( O
25 O
/ O
28 O
) O
in O
Groups O
B O
and O
C O
( O
p O
= O
0 O
. O
764 O
) O
. O

A O
total O
of O
74 O
patients Habitat_B
( O
88 O
% O
) O
were O
free O
from O
symptoms O
at O
the O
end O
of O
the O
triple O
therapy O
. O

Symptom O
relief O
was O
faster O
in O
patients Habitat_B
with Habitat_I
PPI Habitat_I
- Habitat_I
based Habitat_I
triple Habitat_I
therapy Habitat_I
( O
Groups O
B O
and O
C O
) O
( O
days O
3 O
and O
4 O
) O
than O
for O
patients Habitat_B
with Habitat_I
bismuth Habitat_I
- Habitat_I
based Habitat_I
triple Habitat_I
therapy Habitat_I
( O
day O
5 O
) O
. O

The O
cost O
of O
Group O
C O
therapy O
was O
lower O
than O
that O
for O
Groups O
A O
and O
B O
. O

There O
were O
no O
major O
side O
- O
effects O
in O
any O
of O
the O
patients Habitat_B
. O

One O
- O
week O
triple O
therapy O
with O
omeprazole O
, O
clarithromycin O
and O
metronidazole O
is O
highly O
effected O
for O
the O
eradication O
of O
H Bacteria_B
pylori Bacteria_I
. O

A O
therapeutic O
regime O
of O
one O
week O
' O
s O
duration O
with O
lower O
cost O
, O
good O
compliance O
and O
mild O
side O
- O
effects O
may O
offer O
a O
good O
choice O
for O
treatment O
of O
duodenal Habitat_B
ulcer Habitat_I
associated O
with O
H Bacteria_B
pylori Bacteria_I
infection O
in O
clinical O
practice O
. O

Characterization O
of O
a O
lipopolysaccharide O
- O
targeted O
monoclonal O
antibody O
and O
its O
variable O
fragments O
as O
candidates O
for O
prophylaxis O
against O
the O
obligate O
intracellular O
bacterial O
pathogen O
Coxiella Bacteria_B
burnetii Bacteria_I
. O

Our O
previous O
study O
demonstrated O
that O
treatment O
of O
Coxiella Bacteria_B
burnetii Bacteria_I
with O
the O
phase O
I O
lipopolysaccharide O
( O
PI O
- O
LPS O
) O
- O
targeted O
monoclonal O
antibody O
( O
MAb O
) O
1E4 O
significantly O
inhibited O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
infection O
in O
mice Habitat_B
, O
suggesting O
that O
1E4 O
is O
a O
protective O
MAb O
. O

To O
determine O
whether O
passive O
transfer O
of O
antibodies O
( O
Abs O
) O
can O
provide O
protection O
against O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
natural O
infection O
, O
we O
examined O
if O
passive O
transfer O
of O
1E4 O
would O
protect O
SCID Habitat_B
mice Habitat_I
against O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
aerosol Habitat_B
infection O
. O

The O
results O
indicated O
that O
1E4 O
conferred O
significant O
protection O
against O
aerosolized Habitat_B
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
, O
suggesting O
that O
1E4 O
may O
be O
useful O
for O
preventing O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
natural O
infection O
. O

To O
further O
understand O
the O
mechanisms O
of O
1E4 O
- O
mediated O
protection O
and O
to O
test O
the O
possibility O
of O
using O
humanized O
1E4 O
to O
prevent O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
infection O
, O
we O
examined O
whether O
the O
Fab O
fragment O
of O
1E4 O
( O
Fab1E4 O
) O
, O
a O
recombinant O
murine Habitat_B
single O
- O
chain O
variable O
fragment O
( O
muscFv1E4 O
) O
, O
and O
a O
humanized O
single O
- O
chain O
variable O
fragment O
( O
huscFv1E4 O
) O
retained O
the O
ability O
of O
1E4 O
to O
inhibit O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
infection O
. O

The O
results O
indicated O
that O
Fab1E4 O
, O
muscFv1E4 O
, O
and O
huscFv1E4 O
were O
able O
to O
inhibit O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
infection O
in O
mice Habitat_B
but O
that O
their O
ability O
to O
inhibit O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
infection O
was O
lower O
than O
that O
of O
1E4 O
. O

In O
addition O
, O
treatment O
of O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
with O
Fab1E4 O
, O
muscFv1E4 O
, O
or O
huscFv1E4 O
can O
block O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
infection O
of O
macrophages Habitat_B
. O

Interestingly O
, O
treatment O
of O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
with O
huscFv1E4 O
can O
significantly O
reduce O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
infectivity O
in O
human Habitat_B
macrophages Habitat_I
. O

This O
report O
provides O
the O
first O
evidence O
to O
demonstrate O
that O
the O
humanized O
variable O
fragments O
of O
an O
LPS O
- O
specific O
MAb O
can O
neutralize O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
infection O
and O
appears O
to O
be O
a O
promising O
step O
toward O
the O
potential O
use O
of O
a O
humanized O
MAb O
as O
emergency O
prophylaxis O
against O
C Bacteria_B
. Bacteria_I
burnetii Bacteria_I
exposure O
. O

Cloning O
, O
expression O
, O
purification O
, O
crystallization O
and O
X O
- O
ray O
crystallographic O
analysis O
of O
Rv3168 O
from O
Mycobacterium Bacteria_B
tuberculosis Bacteria_I
H37Rv Bacteria_I
. O

Tuberculosis O
is O
a O
widespread O
and O
deadly O
infectious O
disease O
, O
with O
one O
third O
of O
the O
human Habitat_B
population Habitat_I
already O
being O
infected O
. O

Aminoglycoside O
antibiotics O
have O
become O
less O
effective O
in O
recent O
years O
owing O
to O
antibiotic O
resistance O
, O
which O
arises O
primarily O
through O
enzymatic O
modification O
of O
the O
antibiotics O
. O

The O
gene O
product O
Rv3168 O
, O
a O
putative O
aminoglycoside O
phosphotransferase O
( O
APH O
) O
, O
from O
Mycobacterium Bacteria_B
tuberculosis Bacteria_I
was O
crystallized O
using O
the O
sitting O
- O
drop O
vapour O
- O
diffusion O
method O
in O
the O
presence O
of O
0 O
. O
2 O
M O
calcium O
acetate O
, O
0 O
. O
1 O
M O
Tris O
- O
HCl O
pH O
7 O
. O
0 O
and O
20 O
% O
PEG O
3000 O
at O
295 O
K O
. O
X O
- O
ray O
diffraction O
data O
were O
collected O
to O
a O
maximum O
resolution O
of O
1 O
. O
67 O
Å O
on O
a O
synchrotron O
beamline O
. O

The O
crystal O
belonged O
to O
space O
group O
P2 O
( O
1 O
) O
2 O
( O
1 O
) O
2 O
( O
1 O
) O
, O
with O
unit O
- O
cell O
parameters O
a O
= O
56 O
. O
74 O
, O
b O
= O
62 O
. O
37 O
, O
c O
= O
103 O
. O
61 O
Å O
. O

With O
one O
molecule O
per O
asymmetric O
unit O
, O
the O
crystal O
volume O
per O
unit O
protein O
weight O
( O
V O
( O
M O
) O
) O
is O
2 O
. O
91 O
Å O
( O
3 O
) O
Da O
( O
- O
1 O
) O
. O

The O
structure O
was O
solved O
by O
the O
single O
- O
wavelength O
anomalous O
dispersion O
method O
and O
refinement O
of O
the O
selenomethionine O
structure O
is O
in O
progress O
. O

Methods O
for O
the O
detection O
of O
a O
specific O
Mycobacterium Bacteria_B
leprae Bacteria_I
antigen O
in O
the O
urine Habitat_B
of Habitat_I
leprosy Habitat_I
patients Habitat_I
. O

Two O
methods O
for O
detecting O
the O
phenolic O
glycolipid O
, O
PGL O
- O
1 O
, O
a O
Mycobacterium Bacteria_B
leprae Bacteria_I
- O
specific O
molecule O
, O
in O
the O
urine Habitat_B
of Habitat_I
leprosy Habitat_I
patients Habitat_I
are O
described O
. O

Both O
methods O
rely O
on O
the O
100 O
- O
fold O
preconcentration O
of O
the O
urine Habitat_B
, O
which O
can O
be O
accomplished O
by O
a O
single O
- O
step O
ultrafiltration O
procedure O
. O

The O
equivalent O
of O
approximately O
2 O
. O
5 O
micrograms O
of O
PGL O
- O
1 O
/ O
ml O
was O
detected O
in O
the O
urine Habitat_B
of Habitat_I
LL Habitat_I
patients Habitat_I
with O
an O
inhibition O
ELISA O
. O

The O
second O
method O
, O
a O
direct O
dot O
- O
blot O
assay O
on O
nitrocellulose Habitat_B
paper Habitat_I
, O
was O
much O
simpler O
and O
more O
sensitive O
. O

As O
little O
as O
3 O
ng O
of O
antigen O
was O
detected O
by O
the O
dot O
- O
blot O
technique O
. O

PGL O
- O
1 O
was O
detected O
in O
the O
urine Habitat_B
of Habitat_I
LL Habitat_I
patients Habitat_I
. O

A O
general O
strategy O
for O
the O
bacterial O
expression O
of O
amyloidogenic O
peptides O
using O
BCL O
- O
XL O
- O
1 O
/ O
2 O
fusions O
. O

Biophysical O
studies O
on O
amyloidogenic O
and O
aggregation O
- O
prone O
peptides O
often O
require O
large O
quantities O
of O
material O
. O

However O
, O
solid O
- O
phase O
synthesis O
, O
handling O
, O
and O
purification O
of O
peptides O
often O
present O
challenges O
on O
these O
scales O
. O

Recombinant O
expression O
is O
an O
attractive O
alternative O
because O
of O
its O
low O
cost O
, O
the O
ability O
to O
isotopically O
label O
the O
peptides O
, O
and O
access O
to O
sequences O
exceeding O
approximately O
50 O
residues O
. O

However O
, O
expression O
systems O
that O
seek O
to O
solubilize O
amyloidogenic O
peptides O
suffer O
from O
low O
yields O
, O
difficult O
optimizations O
, O
and O
isolation O
challenges O
. O

We O
present O
a O
general O
strategy O
for O
expressing O
and O
isolating O
amyloidogenic O
peptides O
in O
Escherichia Bacteria_B
coli Bacteria_I
by O
fusion O
to O
a O
polypeptide O
that O
drives O
the O
expression O
of O
attached O
peptides O
into O
bacterial O
inclusion O
bodies O
. O

This O
scheme O
minimizes O
toxicity O
during O
bacterial O
growth O
and O
enables O
the O
processing O
and O
handling O
of O
the O
peptides O
in O
denaturing O
solutions O
. O

Immobilized O
metal O
affinity O
chromatography O
, O
reverse O
phase O
HPLC O
, O
and O
cyanogen O
bromide O
cleavage O
are O
used O
to O
isolate O
the O
peptide O
, O
followed O
by O
further O
reverse O
phase O
HPLC O
, O
which O
yields O
milligram O
quantities O
of O
the O
purified O
peptide O
. O

We O
demonstrate O
that O
driving O
the O
peptides O
into O
inclusion O
bodies O
using O
fusion O
to O
BCL O
- O
XL O
- O
1 O
/ O
2 O
is O
a O
general O
strategy O
for O
their O
expression O
and O
isolation O
, O
as O
exemplified O
by O
the O
production O
of O
11 O
peptides O
species O
. O

Clonal O
strains O
of O
Pseudomonas Bacteria_B
aeruginosa Bacteria_I
in O
paediatric Habitat_B
and O
adult Habitat_B
cystic O
fibrosis O
units O
. O

Despite O
recent O
reports O
of O
clonal O
strains O
of O
Pseudomonas Bacteria_B
aeruginosa Bacteria_I
in O
cystic Habitat_B
fibrosis Habitat_I
( Habitat_I
CF Habitat_I
) Habitat_I
units Habitat_I
, O
the O
need O
for O
routine O
microbiological O
surveillance O
remains O
contentious O
. O

Sputum Habitat_B
was O
collected O
prospectively O
from O
productive Habitat_B
patients Habitat_I
attending O
the O
regional O
paediatric Habitat_B
and O
adult Habitat_B
CF O
units O
in O
Brisbane O
, O
Australia O
. O

All O
P Bacteria_B
. Bacteria_I
aeruginosa Bacteria_I
isolates O
were O
typed O
using O
pulsed O
- O
field O
gel O
electrophoresis O
. O

Spirometry O
, O
anthropometrics O
, O
hospitalisations O
and O
antibiotic O
sensitivity O
data O
were O
recorded O
. O

The O
first O
100 O
sputum Habitat_B
samples O
( O
first O
50 O
patients Habitat_B
at O
each O
clinic Habitat_B
) O
harboured O
163 O
isolates O
of O
P Bacteria_B
. Bacteria_I
aeruginosa Bacteria_I
. O

A O
total O
of O
39 O
patients Habitat_B
shared O
a O
common O
strain O
( O
pulsotype O
2 O
) O
, O
20 O
patients Habitat_B
shared O
a O
strain O
with O
at O
least O
one O
other O
patient Habitat_B
and O
41 O
patients Habitat_B
harboured O
unique O
strains O
. O

Eight O
patients Habitat_B
shared O
a O
strain O
identical O
to O
a O
previously O
reported O
Australian O
transmissible O
strain O
( O
pulsotype O
1 O
) O
. O

Compared O
with O
the O
unique O
strain O
group O
, O
patients Habitat_B
harbouring O
pulsotype O
2 O
were O
younger O
and O
had O
poorer O
lung Habitat_B
function O
. O

Treatment O
requirements O
were O
similar O
in O
these O
two O
groups O
, O
as O
were O
the O
rates O
of O
multiresistance O
. O

In O
conclusion O
, O
59 O
% O
of O
patients Habitat_B
harboured O
a O
clonal O
strain O
, O
supporting O
the O
need O
for O
routine O
microbiological O
surveillance O
. O

In O
contrast O
to O
previously O
described O
clonal O
strains O
, O
the O
dominant O
pulsotype O
was O
indistinguishable O
from O
nonclonal O
strains O
with O
respect O
to O
both O
colonial O
morphology O
and O
multiresistance O
. O

The O
clinical O
significance O
of O
clonal O
strains O
remains O
uncertain O
and O
requires O
longitudinal O
study O
. O

Association O
of O
mutation O
patterns O
in O
GyrA O
and O
ParC O
genes O
with O
quinolone O
resistance O
levels O
in O
lactic Bacteria_B
acid Bacteria_I
bacteria Bacteria_I
. O

The O
quinolone O
resistance O
of O
19 O
lactic Bacteria_B
acid Bacteria_I
bacterial Bacteria_I
strains O
belonging O
to O
the O
genera O
Enterococcus Bacteria_B
and O
Lactobacillus Bacteria_B
isolated O
from O
the O
natural Habitat_B
fermented Habitat_I
koumiss Habitat_I
and O
yoghurt Habitat_B
were O
investigated O
. O

The O
objective O
of O
this O
study O
was O
to O
determine O
the O
quinolone O
resistance O
levels O
and O
to O
explore O
the O
association O
of O
the O
resistance O
with O
the O
mutation O
patterns O
in O
gyrA O
and O
parC O
genes O
, O
as O
is O
currently O
recommended O
by O
the O
Food O
and O
Agriculture O
Organization O
/ O
World O
Health O
Organization O
Joint O
Expert O
Committee O
in O
Guidelines O
for O
Evaluation O
of O
Probiotics O
in O
Food O
for O
probiotic O
lactic Bacteria_B
acid Bacteria_I
bacteria Bacteria_I
drug O
resistance O
in O
2001 O
. O

The O
Oxford O
Cup O
method O
and O
double O
- O
tube O
dilution O
method O
were O
used O
to O
determine O
the O
quinolone O
resistance O
levels O
of O
the O
isolated O
strains O
. O

Generally O
, O
all O
of O
the O
19 O
strains O
showed O
resistance O
towards O
norfloxacin O
and O
ciprofloxacin O
when O
the O
Oxford O
cup O
method O
was O
used O
, O
whereas O
the O
incidence O
was O
lower O
( O
to O
norfloxacin O
89 O
. O
5 O
% O
and O
to O
ciprofloxacin O
68 O
. O
4 O
% O
) O
when O
minimum O
inhibitory O
concentration O
breakpoints O
( O
CLSI O
M100 O
- O
S23 O
) O
were O
tested O
. O

Furthermore O
, O
gene O
sequencing O
was O
conducted O
on O
gyrA O
and O
parC O
of O
topoisomerase O
II O
of O
these O
isolated O
strains O
. O

The O
genetic O
basis O
for O
quinolone O
resistance O
may O
be O
closely O
related O
to O
mutations O
in O
gyrA O
genes O
as O
there O
were O
10 O
mutation O
sites O
in O
amino O
- O
acid O
sequences O
encoded O
by O
gyrA O
genes O
in O
10 O
quinolone O
resistance O
strains O
and O
14 O
mutation O
sites O
in O
Enterococcus Bacteria_B
durans Bacteria_I
HZ28 Bacteria_I
, O
whereas O
no O
typical O
mutations O
were O
detected O
in O
parC O
genes O
. O

Construction O
of O
a O
cloning O
vector O
from O
a O
naturally O
occurring O
plasmid O
of O
Salmonella Bacteria_B
typhimurium Bacteria_I
. O

A O
naturally O
occurring O
plasmid O
isolated O
from O
a O
drug O
- O
resistant O
strain O
of O
Salmonella Bacteria_B
typhimurium Bacteria_I
( Bacteria_I
993 Bacteria_I
) Bacteria_I
has O
been O
used O
to O
construct O
a O
plasmid O
vector O
for O
cloning O
in O
a O
wild O
strain O
of O
Salmonella Bacteria_B
. O

The O
strain O
( Bacteria_B
993 Bacteria_I
) Bacteria_I
contains O
at O
least O
two O
plasmids O
. O

The O
smaller O
plasmid O
( O
9 O
kb O
) O
contains O
an O
ampicillin O
- O
resistant O
marker O
, O
while O
the O
larger O
one O
( O
25 O
kb O
) O
is O
cryptic O
. O

Physical O
mapping O
of O
the O
9 O
- O
kb O
plasmid O
and O
construction O
of O
a O
3 O
. O
5 O
- O
kb O
derivative O
have O
been O
carried O
out O
. O

This O
plasmid O
has O
been O
used O
for O
cloning O
in O
a O
restriction O
+ O
modification O
+ O
strain O
of O
S Bacteria_B
. Bacteria_I
typhimurium Bacteria_I
using O
a O
conventional O
calcium O
chloride O
method O
. O

It O
exhibited O
better O
efficiency O
of O
transformation O
than O
other O
commonly O
used O
plasmids O
such O
as O
pBR322 O
or O
its O
derivatives O
and O
transformants O
were O
found O
to O
be O
stable O
in O
the O
absence O
of O
antibiotic O
selection O
. O

The O
vector O
is O
compatible O
with O
pBR322 O
and O
can O
be O
used O
to O
study O
the O
expression O
of O
cloned O
genes O
in O
minicells O
. O

Lipopolysaccharide O
from O
nonvirulent O
Ara Bacteria_B
+ Bacteria_I
Burkholderia Bacteria_I
pseudomallei Bacteria_I
isolates O
is O
immunologically O
indistinguishable O
from O
lipopolysaccharide O
from O
virulent O
Ara Bacteria_B
- Bacteria_I
clinical Habitat_B
isolates O
. O

Different O
lines O
of O
evidence O
suggest O
that O
a O
discrepancy O
between O
the O
distribution O
of O
Burkholderia O
( O
Pseudomonas O
) O
pseudomallei O
in O
the O
environment O
and O
the O
distribution O
of O
the O
disease O
melioidosis O
is O
attributable O
, O
at O
least O
in O
part O
, O
to O
phenotypic O
differences O
between O
clinical Habitat_B
and O
some O
environmental O
isolates O
. O

Two O
antigenically O
and O
biochemically O
distinct O
biotypes O
have O
been O
described O
, O
only O
one O
of O
which O
is O
virulent O
. O

In O
this O
study O
, O
lipopolysaccharides O
( O
LPSs O
) O
were O
extracted O
by O
the O
proteinase O
K O
digestion O
method O
from O
a O
total O
of O
214 O
B Bacteria_B
. Bacteria_I
pseudomallei Bacteria_I
isolates O
, O
and O
their O
immunoreactivities O
with O
sera Habitat_B
from Habitat_I
patients Habitat_I
with Habitat_I
different Habitat_I
clinical Habitat_I
spectra Habitat_I
and Habitat_I
with Habitat_I
other Habitat_I
infections Habitat_I
were O
evaluated O
. O

With O
the O
exception O
of4 O
isolates O
from O
a O
total O
of O
214 O
tested O
, O
the O
sodium O
dodecyl O
sulfate O
- O
polyacrylamide O
gel O
electrophoresis O
silver O
- O
staining O
profiles O
of O
the O
LPSs O
from O
the O
two O
biotypes O
showed O
identical O
ladder O
patterns O
that O
were O
typical O
for O
smooth O
LPSs O
from O
other O
gram O
- O
negative O
bacteria O
. O

The O
210 O
isolates O
with O
typical O
LPS O
patterns O
( O
119 O
Ara Bacteria_B
- Bacteria_I
clinical Habitat_B
, O
13 O
Ara Bacteria_B
- Bacteria_I
soil Habitat_B
, O
70 O
Ara Bacteria_B
+ Bacteria_I
soil Habitat_B
, O
and O
8 O
reference O
National O
Type O
Culture O
Collection O
strains O
) O
also O
exhibited O
similar O
immunoblot O
profiles O
against O
pooled O
sera Habitat_B
from Habitat_I
patients Habitat_I
with Habitat_I
melioidosis Habitat_I
and O
hyperimmune Habitat_B
mouse Habitat_I
sera Habitat_I
. O

Concordant O
findings O
were O
noted O
in O
the O
indirect O
enzyme O
- O
linked O
immunosorbent O
assay O
with O
Ara Bacteria_B
- Bacteria_I
and O
Ara Bacteria_B
+ Bacteria_I
LPSs O
to O
coat O
the O
microtiter O
plates O
. O

The O
LPSs O
of O
the O
different O
B Bacteria_B
. Bacteria_I
pseudomallei Bacteria_I
biotypes O
appear O
antigenically O
indistinguishable O
. O

It O
is O
, O
therefore O
, O
unlikely O
that O
this O
component O
is O
related O
to O
the O
virulence O
and O
pathogenicity O
of O
B Bacteria_B
. Bacteria_I
pseudomallei Bacteria_I
. O

Human Habitat_B
and O
tick Habitat_B
spotted Bacteria_B
fever Bacteria_I
group Bacteria_I
Rickettsia Bacteria_B
isolates O
from O
Israel O
: O
a O
genotypic O
analysis O
. O

The O
genomes O
of O
spotted Bacteria_B
fever Bacteria_I
group Bacteria_I
rickettsiae Bacteria_B
isolated O
in O
different O
geographical O
areas O
of O
Israel O
( O
two O
from O
ticks Habitat_B
and O
four O
from O
humans Habitat_B
, O
obtained O
over O
a O
span O
of O
20 O
years O
) O
were O
studied O
by O
polymerase O
chain O
reaction O
( O
PCR O
) O
and O
restriction O
endonuclease O
fragment O
length O
polymorphism O
( O
RFLP O
) O
analysis O
. O

The O
human Habitat_B
isolates O
were O
obtained O
from O
patients Habitat_B
suffering Habitat_I
from Habitat_I
rickettsial Habitat_I
disease Habitat_I
of Habitat_I
different Habitat_I
degrees Habitat_I
of Habitat_I
severity Habitat_I
. O

The O
PCR O
products O
obtained O
with O
five O
pairs O
of O
oligonucleotide O
primers O
( O
two O
primer O
sets O
derived O
from O
the O
190 O
- O
kDa O
polypeptide O
gene O
and O
three O
from O
the O
120 O
- O
kDa O
polypeptide O
gene O
) O
and O
cleaved O
with O
restriction O
endonucleases O
were O
used O
to O
study O
the O
Israeli O
isolates O
and O
reference O
Rickettsia Bacteria_B
conorii Bacteria_I
isolates O
. O

Subtle O
differences O
between O
the O
PCR O
- O
RFLP O
patterns O
of O
Israeli O
isolates O
and O
the O
two O
R O
. O
conorii O
reference O
strains O
( O
Moroccan O
and O
no O
. O

7 O
) O
were O
seen O
when O
the O
PCR O
products O
derived O
from O
the O
190 O
- O
kDa O
gene O
- O
derived O
primer O
sets O
were O
digested O
. O

All O
of O
the O
Israeli O
isolates O
were O
identical O
by O
RFLP O
analysis O
using O
all O
of O
the O
primer O
sets O
. O

This O
study O
showed O
that O
the O
Israeli O
spotted Bacteria_B
fever Bacteria_I
group Bacteria_I
isolates O
( O
from O
both O
ticks Habitat_B
and O
humans Habitat_B
) O
were O
genetically O
homogeneous O
by O
the O
criteria O
used O
in O
this O
study O
, O
despite O
the O
time O
and O
location O
differences O
in O
their O
original O
isolation O
, O
and O
different O
as O
a O
group O
from O
R Bacteria_B
. Bacteria_I
conorii Bacteria_I
. O

Characterization O
of O
a O
mosquitocidal O
Bacillus Bacteria_B
thuringiensis Bacteria_I
serovar Bacteria_I
sotto Bacteria_I
strain O
isolated O
from O
Okinawa O
, O
Japan O
. O

To O
characterize O
the O
mosquitocidal O
activity O
of O
parasporal O
inclusions O
of O
the O
Bacillus Bacteria_B
thuringiensis Bacteria_I
serovar Bacteria_I
sotto Bacteria_I
strain Bacteria_I
96 Bacteria_I
- Bacteria_I
OK Bacteria_I
- Bacteria_I
85 Bacteria_I
- Bacteria_I
24 Bacteria_I
, O
for O
comparison O
with O
two O
well O
- O
characterized O
mosquitocidal O
strains O
. O

The O
strain O
96 Bacteria_B
- Bacteria_I
OK Bacteria_I
- Bacteria_I
85 Bacteria_I
- Bacteria_I
24 Bacteria_I
significantly O
differed O
from O
the O
existing O
mosquitocidal O
B Bacteria_B
. Bacteria_I
thuringiensis Bacteria_I
strains O
in O
: O
( O
1 O
) O
lacking O
the O
larvicidal O
activity O
against O
Culex Habitat_B
pipiens Habitat_I
molestus Habitat_I
and O
haemolytic O
activity O
, O
and O
( O
2 O
) O
SDS O
- O
PAGE O
profiles O
, O
immunological O
properties O
and O
N O
- O
terminal O
amino O
acid O
sequences O
of O
parasporal O
inclusion O
proteins O
. O

It O
is O
clear O
from O
the O
results O
that O
the O
strain O
96 Bacteria_B
- Bacteria_I
OK Bacteria_I
- Bacteria_I
85 Bacteria_I
- Bacteria_I
24 Bacteria_I
synthesizes O
a O
novel O
mosquitocidal O
Cry O
protein O
with O
a O
unique O
toxicity O
spectrum O
. O

This O
is O
the O
first O
report O
of O
the O
occurrence O
of O
a O
mosquitocidal O
B Bacteria_B
. Bacteria_I
thuringiensis Bacteria_I
strain O
with O
an O
unusual O
toxicity O
spectrum O
, O
lacking O
the O
activity O
against O
the O
culicine Habitat_B
mosquito Habitat_I
. O

Evaluation O
of O
two O
commercial O
methods O
for O
the O
detection O
of O
Listeria Bacteria_B
sp Bacteria_I
. Bacteria_I

and O
Listeria Bacteria_B
monocytogenes Bacteria_I
in O
a O
chicken Habitat_B
nugget Habitat_I
processing Habitat_I
plant Habitat_I
. O

This O
study O
measures O
the O
detection O
performances O
of O
two O
rapid O
test O
systems O
( O
Listeria O
Rapid O
Test O
Clearview O
and O
Bax O
system O
) O
for O
the O
screening O
of O
Listeria Bacteria_B
sp Bacteria_I
. Bacteria_I

and O
Listeria Bacteria_B
monocytogenes Bacteria_I
, O
respectively O
. O

A O
total O
of O
413 O
samples O
from O
different O
sources O
( O
product O
from O
( O
i O
) O
different O
stages O
of O
processing O
, O
( O
ii O
) O
different O
environments O
, O
and O
( O
iii O
) O
different O
food Habitat_B
handlers O
) O
, O
collected O
from O
a O
chicken Habitat_B
nugget Habitat_I
processing Habitat_I
plant Habitat_I
, O
were O
analysed O
by O
both O
rapid O
methods O
and O
a O
cultural O
method O
consisting O
of O
pre O
- O
enrichment O
, O
enrichment O
, O
and O
isolation O
onto O
selective Habitat_B
agars Habitat_I
( O
PALCAM Habitat_B
, O
LPM Habitat_B
, O
and O
HCLA Habitat_B
) O
. O

Overall O
, O
results O
showed O
an O
excellent O
correlation O
between O
data O
obtained O
using O
Clearview O
and O
the O
cultural O
method O
, O
with O
Clearview O
presenting O
an O
efficiency O
of O
99 O
% O
. O

Bax O
showed O
a O
lower O
correlation O
using O
the O
cultural O
method O
, O
with O
an O
efficiency O
of O
71 O
. O
1 O
% O
. O

The O
type O
of O
sample O
did O
not O
affect O
the O
efficiency O
of O
Clearview O
, O
which O
varied O
from O
98 O
. O
1 O
% O
for O
product Habitat_B
samples Habitat_I
to O
100 O
% O
for O
environmental O
and O
food Habitat_B
handler Habitat_I
samples O
, O
while O
for O
Bax O
it O
had O
a O
marked O
influence O
. O

Efficiency O
of O
Bax O
varied O
from O
as O
high O
as O
100 O
% O
for O
food Habitat_B
handlers O
to O
37 O
. O
9 O
% O
for O
product Habitat_B
samples Habitat_I
. O

Long O
- O
term O
Helicobacter Bacteria_B
pylori Bacteria_I
infection O
and O
the O
development O
of O
atrophic O
gastritis O
and O
gastric Habitat_B
cancer O
in O
Japan O
. O

The O
incidence O
of O
gastric Habitat_B
cancer O
and O
the O
prevalence O
of O
Helicobacter Bacteria_B
pylori Bacteria_I
are O
high O
in O
Japan O
, O
so O
it O
is O
an O
important O
issue O
whether O
long O
- O
term O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
leads O
to O
chronic O
atrophic O
gastritis O
, O
considered O
one O
of O
the O
precursors O
of O
gastric Habitat_B
cancer O
. O

We O
have O
reported O
that O
the O
grade O
of O
atrophy O
was O
higher O
in O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
- O
positive O
subjects O
than O
in O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
- O
negative O
subjects O
. O

It O
has O
also O
been O
reported O
that O
the O
atrophy O
of O
gastric Habitat_B
mucosa O
increased O
in O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
- O
infected O
monkeys O
compared O
with O
control Habitat_B
monkeys Habitat_I
in O
a O
5 O
- O
year O
follow O
- O
up O
study O
. O

Most O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infections O
occur O
in O
children Habitat_B
, O
and O
atrophy O
of O
the O
gastric Habitat_B
mucosa Habitat_I
progresses O
during O
aging O
. O

Long O
- O
term O
data O
show O
that O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
can O
lead O
to O
gastric Habitat_B
atrophy O
and O
may O
play O
an O
important O
role O
in O
the O
development O
of O
gastric Habitat_B
cancer O
. O

Interestingly O
, O
there O
was O
no O
difference O
in O
the O
prevalence O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
between O
patients Habitat_B
with Habitat_I
chronic Habitat_I
gastritis Habitat_I
and O
gastric Habitat_B
cancer O
in O
Japan O
, O
but O
the O
prevalence O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
in O
young Habitat_B
Japanese Habitat_I
gastric Habitat_I
cancer Habitat_I
patients Habitat_I
was O
significantly O
higher O
than O
in O
the O
control O
group O
. O

These O
data O
clearly O
show O
that O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
is O
one O
of O
the O
risk O
factors O
of O
gastric Habitat_B
cancer O
in O
young Habitat_B
Japanese Habitat_I
people Habitat_I
, O
There O
is O
no O
answer O
to O
whether O
curing O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
can O
reverse O
the O
atrophy O
of O
the O
gastric Habitat_B
mucosa O
and O
decrease O
the O
risk O
of O
gastric Habitat_B
cancer O
development O
. O

To O
clarify O
this O
issue O
, O
an O
intervention O
study O
must O
be O
done O
. O

A O
large O
clinical O
trial O
called O
the O
Japanese O
Intervention O
Trial O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
is O
in O
progress O
. O

Hg O
( O
II O
) O
sequestration O
and O
protection O
by O
the O
MerR O
metal O
- O
binding O
domain O
( O
MBD O
) O
. O

MerR O
, O
the O
metalloregulator O
of O
the O
bacterial O
mercury O
resistance O
( O
mer O
) O
operon O
, O
binds O
Hg O
( O
II O
) O
with O
high O
affinity O
. O

To O
study O
the O
mechanism O
of O
metal O
- O
induced O
activation O
, O
a O
small O
protein O
was O
previously O
engineered O
embodying O
in O
a O
single O
polypeptide O
the O
metal O
- O
binding O
domain O
( O
MBD O
) O
ordinarily O
formed O
between O
two O
monomers O
of O
MerR O
. O

Here O
the O
physiological O
and O
biochemical O
properties O
of O
MBD O
expressed O
on O
the O
cell O
surface O
or O
in O
the O
cytosol O
were O
examined O
, O
to O
better O
understand O
the O
environments O
in O
which O
specific O
metal O
binding O
can O
occur O
with O
this O
small O
derivative O
. O

Over O
20 O
000 O
surface O
copies O
of O
MBD O
were O
expressed O
per O
Escherichia Bacteria_B
coli Bacteria_I
cell O
, O
with O
metal O
stoichiometries O
of O
approximately O
1 O
. O
0 O
Hg O
( O
II O
) O
per O
MBD O
monomer O
. O

Cells O
expressing O
MBD O
on O
their O
surface O
in O
rich Habitat_B
medium Habitat_I
bound O
6 O
. O
1 O
- O
fold O
more O
Hg O
( O
II O
) O
than O
those O
not O
expressing O
MBD O
. O

Although O
in O
nature O
cells O
use O
the O
entire O
mer O
operon O
to O
detoxify O
mercury O
, O
it O
was O
interesting O
to O
note O
that O
cells O
expressing O
only O
MBD O
survived O
Hg O
( O
II O
) O
challenge O
and O
recovered O
more O
quickly O
than O
cells O
without O
MBD O
. O

Cell O
- O
surface O
- O
expressed O
MBD O
bound O
Hg O
( O
II O
) O
preferentially O
even O
in O
the O
presence O
of O
a O
22 O
- O
fold O
molar O
excess O
of O
Zn O
( O
II O
) O
and O
when O
exposed O
to O
equimolar O
Cd O
( O
II O
) O
in O
addition O
. O

MBD O
expressed O
in O
the O
cystosol O
also O
afforded O
improved O
survival O
from O
Hg O
( O
II O
) O
exposure O
for O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
and O
for O
the O
completely O
unrelated O
bacterium O
Deinococcus Bacteria_B
radiodurans Bacteria_I
. O

Etiology O
and O
epidemiology O
of O
diarrhea O
in O
children Habitat_B
in O
Hanoi O
, O
Vietnam O
. O

This O
paper O
provides O
a O
preliminary O
picture O
of O
diarrhea O
with O
regards O
to O
etiology O
, O
clinical O
symptoms O
, O
and O
some O
related O
epidemiologic O
factors O
in O
children Habitat_B
less Habitat_I
than Habitat_I
five Habitat_I
years Habitat_I
of Habitat_I
age Habitat_I
living O
in O
Hanoi O
, O
Vietnam O
. O

The O
study O
population O
included O
587 O
children Habitat_B
with Habitat_I
diarrhea Habitat_I
and O
249 O
age Habitat_B
- Habitat_I
matched Habitat_I
healthy Habitat_I
controls Habitat_I
. O

The O
identification O
of O
pathogens O
was O
carried O
out O
by O
the O
conventional O
methods O
in O
combination O
with O
ELISA O
, O
immunoseparation O
, O
and O
PCR O
. O

The O
antibiotic O
susceptibility O
was O
determined O
by O
MIC O
following O
the O
NCCLS O
recommendations O
. O

Of O
those O
with O
diarrhea O
, O
40 O
. O
9 O
% O
were O
less O
than O
one O
year O
old O
and O
71 O
. O
0 O
% O
were O
less O
than O
two O
years O
old O
. O

A O
potential O
pathogen O
was O
identified O
in O
67 O
. O
3 O
% O
of O
children Habitat_B
with Habitat_I
diarrhea Habitat_I
. O

They O
were O
group O
A O
rotavirus O
, O
diarrheagenic O
Escherichia Bacteria_B
coli Bacteria_I
, O
Shigella Bacteria_B
spp Bacteria_I
, O
and O
enterotoxigenic O
Bacteroides Bacteria_B
fragilis Bacteria_I
, O
with O
prevalences O
of O
46 O
. O
7 O
% O
, O
22 O
. O
5 O
% O
, O
4 O
. O
7 O
% O
, O
and O
7 O
. O
3 O
% O
, O
respectively O
. O

No O
Salmonella Bacteria_B
spp Bacteria_I
or O
Vibrio Bacteria_B
cholerae Bacteria_I
were O
isolated O
. O

Rotavirus O
and O
diarrheagenic O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
were O
predominant O
in O
children Habitat_B
less Habitat_I
than Habitat_I
two Habitat_I
years Habitat_I
of Habitat_I
age Habitat_I
, O
while O
Shigella Bacteria_B
spp Bacteria_I
, O
and O
enterotoxigenic O
B Bacteria_B
. Bacteria_I
fragilis Bacteria_I
were O
mostly O
seen O
in O
the O
older Habitat_B
children Habitat_I
. O

Diarrheagenic O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
and O
Shigella Bacteria_B
spp Bacteria_I
showed O
high O
prevalence O
of O
resistance O
to O
ampicillin O
, O
chloramphenicol O
, O
and O
to O
trimethoprim O
/ O
sulfamethoxazole O
. O

Children Habitat_B
attending Habitat_I
the Habitat_I
hospitals Habitat_I
had O
fever O
( O
43 O
. O
6 O
% O
) O
, O
vomiting O
( O
53 O
. O
8 O
% O
) O
, O
and O
dehydration O
( O
82 O
. O
6 O
% O
) O
. O

Watery Habitat_B
stool Habitat_I
was O
predominant O
with O
a O
prevalence O
of O
66 O
. O
4 O
% O
, O
followed O
by O
mucous Habitat_B
stool Habitat_I
( O
21 O
. O
0 O
% O
) O
. O

The O
mean O
episodes O
of O
stools Habitat_B
per O
day O
was O
seven O
, O
ranging O
from O
two O
to O
23 O
episodes O
. O

Before O
attending O
hospitals Habitat_B
, O
162 O
/ O
587 O
( O
27 O
. O
6 O
% O
) O
children Habitat_B
had O
been O
given O
antibiotics O
. O

Overall O
, O
more O
children Habitat_B
got O
diarrhea O
in O
( O
i O
) O
poor O
families O
; O
( O
ii O
) O
families O
where O
piped Habitat_B
water Habitat_I
and O
a O
latrine Habitat_B
were O
lacking O
; O
( O
iii O
) O
families O
where O
mothers Habitat_B
washed O
their O
hands O
less O
often O
before O
feeding O
the O
children Habitat_B
; O
( O
iv O
) O
families O
where O
mothers Habitat_B
had O
a O
low O
level O
of O
education O
; O
( O
v O
) O
families O
where O
information O
on O
health O
and O
sanitation O
less O
often O
reached O
their O
households O
. O

Group O
A O
rotavirus O
, O
diarrheagenic O
Escherichia Bacteria_B
coli Bacteria_I
, O
Shigella Bacteria_B
spp Bacteria_I
, O
and O
enterotoxigenic O
Bacteroides Bacteria_B
fragilis Bacteria_I
play O
an O
important O
role O
in O
causing O
diarrhea O
in O
children Habitat_B
in O
Hanoi O
, O
Vietnam O
. O

Epidemiological O
factors O
such O
as O
lack O
of O
fresh Habitat_B
water Habitat_I
supply Habitat_I
, O
unhygienic Habitat_B
septic Habitat_I
tank Habitat_I
, O
low O
family O
income O
, O
lack O
of O
health O
information O
, O
and O
low O
educational O
level O
of O
parents O
could O
contribute O
to O
the O
morbidity O
of O
diarrhea O
in O
children Habitat_B
. O

Neutrophils Habitat_B
are O
resistant O
to O
Yersinia Bacteria_B
YopJ O
/ O
P O
- O
induced O
apoptosis O
and O
are O
protected O
from O
ROS O
- O
mediated O
cell Habitat_B
death O
by O
the O
type O
III O
secretion O
system O
. O

The O
human Habitat_B
innate O
immune O
system O
relies O
on O
the O
coordinated O
activity O
of O
macrophages Habitat_B
and O
polymorphonuclear Habitat_B
leukocytes Habitat_I
( O
neutrophils Habitat_B
or O
PMNs Habitat_B
) O
for O
defense O
against O
bacterial O
pathogens O
. O

Yersinia Bacteria_B
spp O
. O

subvert O
the O
innate Habitat_B
immune Habitat_I
response O
to O
cause O
disease O
in O
humans Habitat_B
. O

In O
particular O
, O
the O
Yersinia Bacteria_B
outer O
protein O
YopJ O
( O
Y Bacteria_B
. Bacteria_I
pestis Bacteria_I
and O
Y Bacteria_B
. Bacteria_I
pseudotuberculosis Bacteria_I
) O
and O
YopP O
( O
Y Bacteria_B
. Bacteria_I
enterocolitica Bacteria_I
) O
rapidly O
induce O
apoptosis O
in O
murine Habitat_B
macrophages Habitat_I
and O
dendritic O
cells O
. O

However O
, O
the O
effects O
of O
Yersinia Bacteria_B
Yop O
J O
/ O
P O
on O
neutrophil Habitat_B
fate O
are O
not O
clearly O
defined O
. O

In O
this O
study O
, O
we O
utilized O
wild O
- O
type O
and O
mutant O
strains O
of O
Yersinia Bacteria_B
to O
test O
the O
contribution O
of O
YopJ O
and O
YopP O
on O
induction O
of O
apoptosis O
in O
human Habitat_B
monocyte O
- O
derived O
macrophages O
( O
HMDM Habitat_B
) O
and O
neutrophils Habitat_B
. O

Whereas O
YopJ O
and O
YopP O
similarly O
induced O
apoptosis O
in O
HMDMs Habitat_B
, O
interaction O
of O
human Habitat_B
neutrophils O
with O
virulence O
plasmid O
- O
containing O
Yersinia Bacteria_B
did O
not O
result O
in O
PMN Habitat_B
caspase O
activation O
, O
release O
of O
LDH O
, O
or O
loss O
of O
membrane O
integrity O
greater O
than O
PMN Habitat_B
controls O
. O

In O
contrast O
, O
interaction O
of O
human Habitat_B
PMNs Habitat_B
with O
the O
virulence O
plasmid O
- O
deficient O
Y Bacteria_B
. Bacteria_I
pestis Bacteria_I
strain Bacteria_I
KIM6 Bacteria_I
resulted O
in O
increased O
surface O
exposure O
of O
phosphatidylserine O
( O
PS O
) O
and O
cell Habitat_B
death O
. O

PMN Habitat_B
reactive O
oxygen O
species O
( O
ROS O
) O
production O
was O
inhibited O
in O
a O
virulence O
plasmid O
- O
dependent O
but O
YopJ O
/ O
YopP O
- O
independent O
manner O
. O

Following O
phagocytic O
interaction O
with O
Y Bacteria_B
. Bacteria_I
pestis Bacteria_I
strain Bacteria_I
KIM6 Bacteria_I
, O
inhibition O
of O
PMN Habitat_B
ROS O
production O
with O
diphenyleneiodonium O
chloride O
resulted O
in O
a O
reduction O
of O
PMN Habitat_B
cell Habitat_I
death O
similar O
to O
that O
induced O
by O
the O
virulence O
plasmid O
- O
containing O
strain O
Y Bacteria_B
. Bacteria_I
pestis Bacteria_I
KIM5 Bacteria_I
. O

Our O
findings O
showed O
that O
Yersinia Bacteria_B
YopJ O
and O
/ O
or O
YopP O
did O
not O
induce O
pronounced O
apoptosis O
in O
human Habitat_B
neutrophils O
. O

Furthermore O
, O
robust O
PMN Habitat_B
ROS O
production O
in O
response O
to O
virulence O
plasmid O
- O
deficient O
Yersinia Bacteria_B
was O
associated O
with O
increased O
PMN Habitat_B
cell Habitat_I
death O
, O
suggesting O
that O
Yersinia Bacteria_B
inhibition O
of O
PMN Habitat_B
ROS O
production O
plays O
a O
role O
in O
evasion O
of O
the O
human Habitat_B
innate Habitat_I
immune Habitat_I
response O
in O
part O
by O
limiting O
PMN Habitat_B
apoptosis O
. O

Lymphogranuloma O
venereum O
presenting O
as O
perianal Habitat_B
ulceration O
: O
an O
emerging O
clinical O
presentation O
? O

An O
outbreak O
of O
lymphogranuloma O
venereum O
( O
LGV O
) O
infection O
has O
been O
recognised O
in O
the O
UK O
since O
2004 O
, O
predominantly O
affecting O
HIV Habitat_B
- Habitat_I
positive Habitat_I
men Habitat_I
who Habitat_I
have Habitat_I
sex Habitat_I
with Habitat_I
men Habitat_I
( O
MSM Habitat_B
) O
. O

Patients Habitat_B
typically O
present O
with O
proctitis O
symptoms O
. O

The O
prevalence O
of O
rectal Habitat_B
LGV O
in O
MSM Habitat_B
attending Habitat_I
sexually Habitat_I
transmitted Habitat_I
infection Habitat_I
clinics Habitat_I
in O
London O
is O
estimated O
at O
1 O
% O
. O

Health O
Protection O
Agency O
surveillance O
has O
shown O
a O
decrease O
in O
anorectal Habitat_B
manifestations O
despite O
little O
demographic O
change O
. O

Two O
cases O
of O
HIV Habitat_B
- Habitat_I
infected Habitat_I
patients Habitat_I
presenting Habitat_I
with Habitat_I
isolated Habitat_I
perianal Habitat_I
ulcer Habitat_I
disease Habitat_I
are O
reported O
here O
. O

Both O
cases O
were O
confirmed O
to O
have O
rectal Habitat_B
Chlamydia Bacteria_B
trachomatis Bacteria_I
- O
specific O
DNA O
of O
an O
LGV O
associated O
serovar O
. O

As O
presentations O
of O
LGV O
diversify O
, O
further O
education O
and O
surveillance O
are O
needed O
in O
order O
to O
reduce O
transmission O
and O
prevent O
long O
- O
term O
complications O
. O

A O
strong O
argument O
already O
exists O
for O
the O
incorporation O
of O
chlamydia Bacteria_B
nucleic O
acid O
amplification O
tests O
in O
the O
management O
of O
MSM Habitat_B
with Habitat_I
proctitis Habitat_I
; O
this O
paper O
provides O
evidence O
that O
this O
should O
be O
extended O
to O
MSM Habitat_B
with Habitat_I
perianal Habitat_I
ulcer Habitat_I
disease Habitat_I
. O

Quantitative O
metabolome O
analysis O
using O
liquid O
chromatography O
- O
high O
- O
resolution O
mass O
spectrometry O
. O

In O
this O
report O
, O
we O
introduce O
a O
liquid O
chromatography O
single O
- O
mass O
spectrometry O
method O
for O
metabolome O
quantification O
, O
using O
the O
LTQ Habitat_B
Orbitrap Habitat_I
high Habitat_I
- Habitat_I
resolution Habitat_I
mass Habitat_I
spectrometer Habitat_I
. O

Analytes O
were O
separated O
with O
hydrophilic O
interaction O
liquid O
chromatography O
. O

At O
a O
working O
resolution O
of O
30 O
, O
000 O
( O
at O
m O
/ O
z O
400 O
) O
, O
the O
limit O
of O
detection O
varied O
from O
50 O
fmol O
to O
5 O
pmol O
for O
25 O
metabolites O
tested O
. O

In O
terms O
of O
metabolite O
concentration O
, O
the O
linearity O
was O
about O
2 O
to O
3 O
orders O
of O
magnitude O
for O
most O
compounds O
( O
R O
( O
2 O
) O
> O
0 O
. O
99 O
) O
. O

To O
determine O
the O
accuracy O
of O
the O
system O
in O
complex O
sample O
matrices O
, O
the O
isotope O
dilution O
method O
was O
evaluated O
from O
mixtures Habitat_B
of Habitat_I
pure Habitat_I
compounds Habitat_I
and Habitat_I
uniformly Habitat_I
13C Habitat_I
- Habitat_I
labeled Habitat_I
cell Habitat_I
extracts Habitat_I
. O

With O
the O
application O
of O
this O
method O
, O
quantification O
was O
possible O
within O
single O
runs O
even O
when O
the O
pool O
sizes O
of O
individual O
metabolites O
varied O
from O
0 O
. O
13 O
to O
55 O
. O
6 O
microM O
. O

As O
a O
case O
study O
, O
intracellular O
concentrations O
of O
central O
metabolites O
were O
determined O
for O
Methylobacterium Bacteria_B
extorquens Bacteria_I
AM1 Bacteria_I
during O
growth O
on O
two O
different O
carbon O
sources O
, O
methanol O
and O
succinate O
. O

Reproducible O
results O
from O
technical O
and O
biological O
repetitions O
were O
obtained O
that O
revealed O
significant O
variations O
of O
intracellular O
metabolite O
pool O
sizes O
, O
depending O
on O
the O
carbon O
source O
. O

The O
LTQ Habitat_B
Obitrap Habitat_I
offers O
new O
perspectives O
and O
strategies O
for O
metabolome O
quantification O
. O

Atypical O
mycobacteria Bacteria_B
causing O
non O
- O
pulmonary Habitat_B
disease O
in O
Queensland O
. O

During O
the O
period O
1971 O
- O
- O
7 O
, O
the O
Tuberculosis O
Reference O
Laboratory O
in O
Queensland O
dealt O
with O
52 O
isolates O
of O
atypical O
mycobacteria Bacteria_B
made O
from O
non O
- O
pulmonary Habitat_B
sites O
under O
circumstances O
suggesting O
complicity O
in O
disease O
. O

Twenty O
- O
four O
isolates O
belonging O
to O
the O
MAIS O
complex O
were O
associated O
with O
lymph Habitat_B
node Habitat_I
infections O
in O
children Habitat_B
. O

Twelve O
isolates O
belonged O
to O
the O
M Bacteria_B
. Bacteria_I
fortuitum Bacteria_I
- Bacteria_I
chelonei Bacteria_I
complex Bacteria_I
; O
most O
were O
from O
superficial Habitat_B
abscesses Habitat_I
. O

Five O
cases O
of O
M Bacteria_B
. Bacteria_I
marinum Bacteria_I
infection O
and O
8 O
of O
M Bacteria_B
. Bacteria_I
ulcerans Bacteria_I
disease O
were O
detected O
. O

Serotypes O
of O
Vibrio Bacteria_B
parahaemolyticus Bacteria_I
from O
clinical Habitat_B
and O
environmental O
sources O
in O
Togo O
( O
West O
Africa O
) O
. O

Serological O
analysis O
of O
O O
and O
K O
antigens O
was O
performed O
on O
343 O
strains O
of O
Vibro Bacteria_B
parahaemolyticus Bacteria_I
isolated O
from O
clinical Habitat_B
and O
environmental O
sources O
in O
Togo O
. O

Only O
two O
strains O
were O
not O
typable O
by O
the O
available O
O O
antisera O
. O

K O
untypable O
strains O
were O
found O
in O
4 O
. O
8 O
% O
of O
isolates O
from O
gastroenteritis Habitat_B
patients Habitat_I
, O
in O
11 O
% O
from O
healthy Habitat_B
carriers Habitat_I
, O
and O
in O
47 O
% O
and O
46 O
% O
of O
isolates O
, O
respectively O
, O
from O
water Habitat_B
and O
fish Habitat_B
samples Habitat_I
. O

Thirteen O
serotypes O
identified O
in O
Togo O
are O
not O
considered O
in O
the O
Japanese O
antigenic O
scheme O
. O

The O
suitability O
of O
the O
Japanese O
typing O
scheme O
for O
geographic O
areas O
outside O
of O
Japan O
is O
discussed O
and O
its O
extension O
is O
suggested O
. O

Enhanced O
virulence O
of O
Chlamydia Bacteria_B
muridarum Bacteria_I
respiratory Habitat_B
infections O
in O
the O
absence O
of O
TLR2 O
activation O
. O

Chlamydia Bacteria_B
trachomatis Bacteria_I
is O
a O
common O
sexually O
transmitted O
pathogen O
and O
is O
associated O
with O
infant Habitat_B
pneumonia O
. O

Data O
from O
the O
female Habitat_B
mouse Habitat_I
model O
of O
genital Habitat_B
tract Habitat_I
chlamydia Bacteria_B
infection O
suggests O
a O
requirement O
for O
TLR2 O
- O
dependent O
signaling O
in O
the O
induction O
of O
inflammation O
and O
oviduct Habitat_B
pathology O
. O

We O
hypothesized O
that O
the O
role O
of O
TLR2 O
in O
moderating O
mucosal Habitat_B
inflammation O
is O
site O
specific O
. O

In O
order O
to O
investigate O
this O
, O
we O
infected O
mice Habitat_B
via O
the O
intranasal Habitat_B
route O
with O
C Bacteria_B
. Bacteria_I
muridarum Bacteria_I
and O
observed O
that O
in O
the O
absence O
of O
TLR2 O
activation O
, O
mice Habitat_B
had O
more O
severe O
disease O
, O
higher O
lung Habitat_B
cytokine O
levels O
, O
and O
an O
exaggerated O
influx O
of O
neutrophils Habitat_B
and O
T Habitat_B
- Habitat_I
cells Habitat_I
into O
the O
lungs Habitat_B
. O

This O
could O
not O
be O
explained O
by O
impaired O
bacterial O
clearance O
as O
TLR2 Habitat_B
- Habitat_I
deficient Habitat_I
mice Habitat_I
cleared O
the O
infection O
similar O
to O
controls O
. O

These O
data O
suggest O
that O
TLR2 O
has O
an O
anti O
- O
inflammatory O
function O
in O
the O
lung Habitat_B
during O
Chlamydia Bacteria_B
infection O
, O
and O
that O
the O
role O
of O
TLR2 O
in O
mucosal Habitat_B
inflammation O
varies O
at O
different O
mucosal Habitat_B
surfaces Habitat_I
. O

Evaluation O
of O
the O
role O
of O
Carnobacterium Bacteria_B
piscicola Bacteria_I
in O
spoilage O
of O
vacuum Habitat_B
- Habitat_I
and Habitat_I
modified Habitat_I
- Habitat_I
atmosphere Habitat_I
- Habitat_I
packed Habitat_I
cold Habitat_I
- Habitat_I
smoked Habitat_I
salmon Habitat_I
stored Habitat_I
at Habitat_I
5 Habitat_I
degrees Habitat_I
C Habitat_I
. O

The O
microflora Habitat_B
on O
spoiled Habitat_B
cold Habitat_I
- Habitat_I
smoked Habitat_I
salmon Habitat_I
often O
consists O
of O
a O
mixture O
of O
lactic Bacteria_B
acid Bacteria_I
bacteria Bacteria_I
( O
LAB Bacteria_B
) O
and O
Gram O
- O
negative O
bacteria O
. O

To O
elucidate O
the O
role O
of O
the O
different O
groups O
, O
a O
storage O
trial O
was O
carried O
out O
in O
which O
nisin O
and O
CO2 O
were O
used O
for O
the O
selective O
inhibition O
of O
the O
two O
bacterial O
groups O
. O

The O
shelf O
- O
life O
of O
vacuum Habitat_B
- Habitat_I
packed Habitat_I
cold Habitat_I
- Habitat_I
smoked Habitat_I
salmon Habitat_I
, O
recorded O
by O
sensory O
evaluation O
, O
was O
four O
weeks O
at O
5 O
degrees O
C O
and O
the O
microflora Habitat_B
was O
composed O
of O
LAB Bacteria_B
( O
10 O
( O
6 O
) O
- O
10 O
( O
7 O
) O
cfu O
/ O
g O
) O
with O
an O
associate O
Gram O
- O
negative O
flora O
in O
varying O
levels O
( O
10 O
( O
5 O
) O
- O
10 O
( O
7 O
) O
cfu O
/ O
g O
) O
. O

The O
addition O
of O
nisin O
and O
/ O
or O
a O
CO2 O
- O
atmosphere O
increased O
the O
shelf O
- O
life O
to O
five O
or O
six O
weeks O
and O
limited O
the O
level O
of O
LAB Bacteria_B
to O
about O
10 O
( O
4 O
) O
- O
10 O
( O
6 O
) O
, O
10 O
( O
3 O
) O
- O
10 O
( O
6 O
) O
and O
10 O
( O
2 O
) O
- O
10 O
( O
4 O
) O
cfu O
/ O
g O
, O
respectively O
. O

CO2 O
- O
atmosphere O
+ O
/ O
- O
nisin O
inhibited O
the O
growth O
of O
Gram O
- O
negative O
bacteria O
, O
whereas O
nisin O
had O
no O
effect O
on O
these O
in O
vacuum Habitat_B
packages Habitat_I
. O

The O
Gram O
- O
negative O
flora O
on O
vacuum Habitat_B
- Habitat_I
packed Habitat_I
salmon Habitat_I
was O
dominated O
by O
a O
Vibrio Bacteria_B
sp Bacteria_I
. Bacteria_I
, O
resembling O
V Bacteria_B
. Bacteria_I
marinus Bacteria_I
, O
Enterobacteriaceae Bacteria_B
( O
Enterobacter Bacteria_B
agglomerans Bacteria_I
, O
Serratia Bacteria_B
liquefaciens Bacteria_I
and O
Rahnella Bacteria_B
aquatilis Bacteria_I
) O
and O
occasionally O
Aeromonas Bacteria_B
hydrophila Bacteria_I
. O

Irrespective O
of O
the O
addition O
of O
nisin O
and O
/ O
or O
CO2 O
- O
atmosphere O
, O
the O
LAB Habitat_B
microflora Habitat_I
was O
dominated O
by O
Carnobacterium Bacteria_B
piscicola Bacteria_I
, O
which O
was O
found O
to O
account O
for O
87 O
% O
of O
the O
255 O
LAB Bacteria_B
isolates O
characterized O
. O

Whole O
- O
cell O
- O
protein O
patterns O
analysed O
by O
SDS O
- O
PAGE O
confirmed O
the O
Carnobacterium Bacteria_B
species O
identification O
. O

The O
spoilage O
potential O
of O
C Bacteria_B
. Bacteria_I
piscicola Bacteria_I
isolates O
was O
further O
studied O
by O
inoculation O
of O
approx O
. O

10 O
( O
6 O
) O
cfu O
/ O
g O
in O
cold Habitat_B
- Habitat_I
smoked Habitat_I
salmon Habitat_I
stored Habitat_I
at Habitat_I
5 Habitat_I
degrees Habitat_I
C Habitat_I
. O
The O
salmon Habitat_B
did O
not O
spoil O
within O
4 O
weeks O
of O
storage O
in O
vacuum O
- O
or O
CO2 O
- O
atmosphere O
, O
and O
it O
is O
concluded O
that O
despite O
high O
levels O
( O
> O
10 O
( O
7 O
) O
cfu O
/ O
g O
) O
of O
C Bacteria_B
. Bacteria_I
piscicola Bacteria_I
, O
sensory O
rejection O
was O
caused O
by O
autolytic O
changes O
. O

This O
was O
supported O
by O
the O
development O
of O
soft O
texture O
and O
sour O
, O
rancid O
and O
bitter O
off O
- O
flavours O
at O
the O
point O
of O
spoilage O
, O
irrespective O
of O
the O
length O
of O
shelf O
- O
life O
and O
low O
or O
high O
total O
counts O
of O
LAB Bacteria_B
and O
Gram O
- O
negative O
bacteria O
. O

Recurrence O
of O
Helicobacter Bacteria_B
pylori Bacteria_I
infection O
1 O
year O
after O
successful O
treatment O
: O
prospective O
cohort O
study O
in O
the O
Republic O
of O
Yemen O
. O

To O
investigate O
the O
prevalence O
of O
Helicobacter Bacteria_B
pylori Bacteria_I
infection O
in O
dyspeptic Habitat_B
patients Habitat_I
in O
the O
Republic O
of O
Yemen O
and O
the O
recurrence O
rate O
1 O
year O
after O
apparently O
successful O
eradication O
. O

A O
total O
of O
275 O
patients Habitat_B
with Habitat_I
chronic Habitat_I
dyspepsia Habitat_I
seen O
in O
one O
clinic Habitat_B
were O
enrolled O
. O

Gastric Habitat_B
biopsies Habitat_I
were O
obtained O
at O
endoscopy O
and O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
was O
diagnosed O
using O
the O
rapid O
urease O
test O
. O

Patients Habitat_B
with Habitat_I
H Habitat_I
. Habitat_I
pylori Habitat_I
infection Habitat_I
were O
given O
either O
clarithromycin O
or O
metronidazole O
- O
based O
triple O
therapy O
. O

Six O
weeks O
later O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
status O
was O
assessed O
using O
the O
C O
- O
urea O
breath O
test O
( O
C O
- O
UBT O
) O
. O

Those O
who O
were O
negative O
for O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
had O
a O
further O
C O
- O
UBT O
after O
1 O
year O
to O
establish O
the O
recurrence O
rate O
. O

The O
prevalence O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
at O
entry O
to O
the O
study O
was O
82 O
. O
2 O
% O
[ O
95 O
% O
confidence O
interval O
( O
CI O
) O
78 O
- O
87 O
% O
] O
. O

The O
overall O
eradication O
rate O
6 O
weeks O
after O
treatment O
was O
49 O
. O
1 O
% O
( O
95 O
% O
CI O
42 O
. O
6 O
- O
55 O
. O
6 O
% O
) O
by O
intention O
- O
to O
- O
treat O
analysis O
, O
and O
60 O
% O
( O
95 O
% O
CI O
53 O
- O
67 O
% O
) O
by O
per O
- O
protocol O
analysis O
. O

Recurrence O
rate O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
at O
1 O
year O
was O
34 O
% O
( O
95 O
% O
CI O
14 O
- O
45 O
% O
) O
and O
the O
only O
predictor O
of O
recurrence O
was O
an O
excess O
delta O
C O
- O
UBT O
value O
less O
than O
3 O
. O
5 O
per O
million O
but O
equal O
to O
or O
greater O
than O
2 O
. O
5 O
per O
million O
at O
6 O
weeks O
after O
treatment O
( O
odds O
ratio O
2 O
. O
28 O
; O
95 O
% O
CI O
1 O
. O
17 O
- O
4 O
. O
44 O
; O
P O
= O
0 O
. O
028 O
) O
. O

The O
prevalence O
of O
H Bacteria_B
. Bacteria_I
pylori Bacteria_I
infection O
in O
dyspeptic Habitat_B
patients Habitat_I
in O
Yemen O
is O
very O
high O
, O
the O
eradication O
rate O
with O
standard O
triple O
therapy O
was O
unsatisfactory O
probably O
because O
of O
widespread O
bacterial O
resistance O
due O
to O
unrestricted O
antibiotic O
use O
. O

The O
recurrence O
rate O
of O
infection O
at O
1 O
year O
was O
high O
, O
as O
a O
result O
of O
recrudescence O
of O
incompletely O
eradicated O
organisms O
rather O
than O
reinfection O
. O

Bile Habitat_B
resistance O
in O
Lactococcus Bacteria_B
lactis Bacteria_I
strains O
varies O
with O
cellular O
fatty O
acid O
composition O
: O
analysis O
by O
using O
different O
growth O
media O
. O

Bile Habitat_B
resistance O
is O
one O
of O
the O
basic O
characteristics O
of O
probiotic O
bacteria O
. O

The O
aim O
of O
this O
study O
was O
to O
investigate O
the O
characteristics O
of O
bile Habitat_B
resistance O
in O
lactococci Bacteria_B
by O
studying O
the O
relationship O
between O
bile Habitat_B
resistance O
and O
cellular O
fatty O
acid O
composition O
in O
lactococcci Bacteria_B
grown O
on O
different O
media O
. O

We O
determined O
the O
bile Habitat_B
resistance O
of O
14 O
strains O
in O
lactose O
- O
free O
M17 O
medium O
supplemented O
with O
either O
glucose O
only O
( O
GM17 O
) O
or O
lactose O
only O
( O
LM17 O
) O
. O

Gas O
chromatographic O
analyses O
of O
free O
lipids O
extracted O
from O
the O
tested O
strains O
were O
used O
for O
determining O
their O
fatty O
acid O
composition O
. O

A O
correlation O
analysis O
of O
all O
strains O
grown O
in O
both O
media O
revealed O
significant O
positive O
correlations O
between O
bile Habitat_B
resistance O
and O
relative O
contents O
of O
hexadecanoic O
acid O
and O
octadecenoic O
acid O
, O
and O
negative O
correlations O
between O
bile Habitat_B
resistance O
and O
relative O
contents O
of O
hexadecenoic O
acid O
and O
C O
- O
19 O
cyclopropane O
fatty O
acid O
. O

It O
is O
also O
a O
fact O
that O
the O
fatty O
acids O
associated O
with O
bile Habitat_B
resistance O
depended O
on O
species O
, O
strain O
, O
and O
/ O
or O
growth O
medium O
. O

In O
L Bacteria_B
. Bacteria_I
lactis Bacteria_I
subsp Bacteria_I
. Bacteria_I
 Bacteria_I
cremoris O
strains O
grown O
in O
GM17 Habitat_B
medium Habitat_I
, O
the O
bile Habitat_B
- O
resistant O
strains O
had O
significantly O
more O
octadecenoic O
acid O
than O
the O
bile Habitat_B
- O
sensitive O
strains O
. O

In O
LM17 Habitat_B
medium Habitat_I
, O
bile Habitat_B
- O
resistant O
strains O
had O
significantly O
more O
octadecenoic O
acid O
and O
significantly O
less O
C O
- O
19 O
cyclopropane O
fatty O
acid O
than O
the O
bile Habitat_B
- O
sensitive O
strains O
. O

In O
L Bacteria_B
. Bacteria_I
lactis Bacteria_I
subsp Bacteria_I
. Bacteria_I
 Bacteria_I
lactis O
strains O
, O
bile Habitat_B
resistances O
of O
some O
of O
the O
tested O
strains O
were O
altered O
by O
growth O
medium O
. O

Some O
strains O
were O
resistant O
to O
bile Habitat_B
in O
GM17 Habitat_B
medium Habitat_I
but O
sensitive O
to O
bile Habitat_B
in O
LM17 Habitat_B
medium Habitat_I
. O

Some O
strains O
were O
resistant O
in O
both O
media O
tested O
. O

The O
strains O
grown O
in O
GM17 Habitat_B
medium Habitat_I
had O
significantly O
more O
hexadecanoic O
acid O
and O
octadecenoic O
acid O
, O
and O
significantly O
less O
tetradecanoic O
acid O
, O
octadecadienoic O
acid O
and O
C O
- O
19 O
cyclopropane O
fatty O
acid O
than O
the O
strains O
grown O
in O
LM17 Habitat_B
medium Habitat_I
. O

In O
conclusion O
, O
the O
fatty O
acid O
compositions O
of O
the O
bile Habitat_B
- O
resistant O
lactococci Bacteria_B
differed O
from O
those O
of O
the O
bile Habitat_B
- O
sensitive O
ones O
. O

More O
importantly O
, O
our O
data O
suggest O
that O
altering O
their O
fatty O
acid O
composition O
( O
i O
. O
e O
. O

increased O
hexadecanoic O
acid O
and O
octadecenoic O
acid O
and O
decreased O
hexadecenoic O
acid O
and O
C O
- O
19 O
cyclopropane O
fatty O
acid O
) O
by O
changing O
growth O
conditions O
may O
be O
a O
useful O
way O
to O
enhance O
their O
bile Habitat_B
resistance O
in O
lactococci Bacteria_B
. O

Early O
pregnancy O
loss O
and O
neonatal Habitat_B
deaths O
associated O
with O
Klebsiella Bacteria_B
pneumonia Bacteria_I
infection O
: O
a O
mini O
review O
of O
possible O
occupational O
health O
risk O
. O

Recurrent O
pregnancy O
loss O
is O
a O
disease O
of O
grave O
psychological O
and O
economic O
concern O
. O

The O
etiology O
in O
the O
vast O
majority O
of O
the O
cases O
is O
unknown O
or O
at O
best O
poorly O
understood O
. O

Although O
Klebsiella Bacteria_B
pneumonia Bacteria_I
infections O
have O
been O
reported O
in O
humans Habitat_B
and O
animals Habitat_B
during O
pregnancy O
, O
there O
is O
hardly O
any O
information O
to O
indicate O
whether O
or O
not O
these O
infections O
may O
be O
responsible O
for O
early O
pregnancy O
loss O
. O

We O
present O
a O
review O
of O
literature O
and O
report O
for O
the O
first O
time O
in O
humans Habitat_B
, O
Klebsiella Bacteria_B
pneumonia Bacteria_I
infection O
in O
placenta Habitat_B
of Habitat_I
a Habitat_I
38 Habitat_I
- Habitat_I
year Habitat_I
- Habitat_I
old Habitat_I
secondary Habitat_I
recurrent Habitat_I
aborter Habitat_I
( O
parity O
2 O
+ O
3 O
) O
. O

Vibrio Bacteria_B
fetus Bacteria_I
human Habitat_B
infection O
- O
- O
isolation O
from O
a O
subacute O
bacterial O
endocarditis O
case O
. O

Effects O
of O
a O
probiotic Habitat_B
fermented Habitat_I
milk Habitat_I
beverage Habitat_I
containing O
Lactobacillus Bacteria_B
casei Bacteria_I
strain Bacteria_I
Shirota Bacteria_I
on O
defecation O
frequency O
, O
intestinal Habitat_B
microbiota Habitat_I
, O
and O
the O
intestinal Habitat_B
environment Habitat_I
of Habitat_I
healthy Habitat_I
individuals Habitat_I
with Habitat_I
soft Habitat_I
stools Habitat_I
. O

The O
effects O
of O
drinking O
a O
fermented Habitat_B
milk Habitat_I
beverage Habitat_I
that O
contains O
Lactobacillus Bacteria_B
casei Bacteria_I
strain Bacteria_I
Shirota Bacteria_I
( O
LcS Bacteria_B
) O
at O
40 O
billion O
bacterial O
cells O
/ O
bottle Habitat_B
for O
4 O
weeks O
( O
probiotics Habitat_B
, O
1 O
bottle Habitat_B
/ O
day O
) O
on O
defecation O
frequency O
, O
intestinal Habitat_B
microbiota O
and O
the O
intestinal Habitat_B
environment Habitat_I
of Habitat_I
healthy Habitat_I
individuals Habitat_I
with Habitat_I
soft Habitat_I
stools Habitat_I
were O
evaluated O
. O

Thirty O
- O
four O
healthy Habitat_B
adults Habitat_I
who O
had O
soft Habitat_B
stools Habitat_I
were O
randomised O
into O
2 O
groups O
, O
and O
the O
effects O
of O
a O
regular O
4 O
- O
week O
intake O
of O
probiotics Habitat_B
were O
evaluated O
by O
a O
placebo O
- O
controlled O
, O
double O
- O
blind O
, O
parallel O
- O
group O
comparative O
design O
. O

Defecation O
frequency O
significantly O
decreased O
after O
the O
4 O
- O
week O
intake O
period O
compared O
with O
before O
the O
probiotic Habitat_B
treatment O
. O

The O
stool Habitat_B
quality O
significantly O
improved O
( O
hardened O
) O
compared O
to O
the O
placebo O
. O

Also O
, O
the O
water Habitat_B
content Habitat_I
of Habitat_I
the Habitat_I
stools Habitat_I
was O
lower O
in O
the O
probiotic Habitat_B
group Habitat_I
than O
in O
the O
placebo Habitat_B
group Habitat_I
. O

Live O
LcS Bacteria_B
was O
recovered O
at O
6 O
. O
9 O
± O
1 O
. O
3 O
and O
7 O
. O
2 O
± O
0 O
. O
8 O
log O
( O
10 O
) O
CFU O
per O
1g O
of O
stool Habitat_B
after O
2 O
and O
4 O
weeks O
, O
respectively O
, O
of O
probiotic Habitat_B
treatment O
. O

The O
number O
of O
bifidobacteria Bacteria_B
in O
the O
stools Habitat_B
also O
increased O
significantly O
compared O
with O
the O
level O
before O
starting O
the O
probiotics Habitat_B
. O

The O
organic O
acid O
levels O
( O
total O
, O
acetic O
acid O
, O
propionic O
acid O
, O
and O
butyric O
acid O
) O
significantly O
increased O
compared O
with O
the O
level O
before O
intake O
in O
both O
the O
probiotic Habitat_B
and O
placebo Habitat_B
groups Habitat_I
, O
but O
they O
returned O
to O
the O
original O
levels O
after O
the O
end O
of O
the O
intake O
period O
. O

These O
results O
suggest O
that O
probiotic Habitat_B
fermented Habitat_I
milk Habitat_I
beverage Habitat_I
has O
an O
intestine Habitat_B
- O
conditioning O
effect O
by O
improving O
the O
frequency O
of O
defecation O
and O
stool Habitat_B
quality O
and O
increasing O
the O
intrinsic O
bifidobacteria Bacteria_B
in O
healthy Habitat_B
individuals Habitat_I
with Habitat_I
soft Habitat_I
stool Habitat_I
. O

A O
cell O
- O
free O
system O
for O
the O
replication O
fo O
bacteriophage O
M O
- O
13 O
duplex O
DNA O
. O

Cell O
- O
free O
extracts O
from O
M O
- O
13 O
am5 O
infected O
Escherichia Bacteria_B
coli Bacteria_I
cells O
which O
are O
highly O
concentrated O
on O
cellophane Habitat_B
membrane Habitat_I
disks Habitat_I
replicate O
efficiently O
endogenous O
M O
- O
13 O
duplex O
DNA O
. O

If O
the O
reaction O
is O
carried O
out O
in O
the O
presence O
of O
bromodeoxyuridine O
triphosphate O
, O
the O
majority O
of O
the O
label O
is O
found O
in O
two O
classes O
of O
hybrid O
DNA O
molecules O
in O
which O
either O
the O
viral O
or O
the O
complementary O
strand O
is O
newly O
synthesized O
. O

A O
minor O
portion O
of O
the O
label O
is O
incorporated O
into O
fully O
synthetic O
duplex O
DNA O
. O

DNA O
synthesis O
requires O
ATP O
and O
is O
inhibited O
by O
nalidixic O
acid O
, O
novobiocin O
, O
and O
arabinosylnucleoside O
triphosphates O
. O

Rifampicin O
blocks O
preferentially O
the O
synthesis O
of O
molecules O
with O
labeled O
complementary O
strands O
. O

A O
similar O
effect O
is O
observed O
upon O
addition O
of O
the O
helix O
- O
destabilising O
M O
- O
13 O
gene O
V O
protein O
. O

In O
contrast O
, O
addition O
of O
E Bacteria_B
. Bacteria_I
coli Bacteria_I
helix O
- O
destabilising O
protein O
( O
Eco Bacteria_B
HD O
- O
protein O
) O
stimulates O
the O
synthesis O
of O
both O
types O
of O
hybrid O
DNA O
molecules O
as O
well O
as O
the O
formation O
of O
fully O
synthetic O
duplex O
DNA O
. O

Prevalence O
of O
thermotolerant O
Campylobacter Bacteria_B
in O
partridges Habitat_B
( O
Perdix Habitat_B
perdix Habitat_I
) O
. O

To O
estimate O
the O
prevalence O
of O
thermotolerant O
Campylobacter Bacteria_B
spp Bacteria_I
. Bacteria_I

in O
commercially Habitat_B
reared Habitat_I
partridges Habitat_I
( O
Perdix Habitat_B
perdix Habitat_I
) O
in O
southern O
Italy O
. O

Cloacal Habitat_B
swabs Habitat_I
of Habitat_I
partridges Habitat_I
( O
n O
= O
240 O
) O
, O
equally O
distributed O
between O
male O
and O
female Habitat_B
birds Habitat_I
, O
from O
a O
game Habitat_B
bird Habitat_I
farm O
located O
in O
the O
Southern O
Italy O
were O
examined O
for O
the O
prevalence O
of O
thermotolerant O
Campylobacter Bacteria_B
spp Bacteria_I
. Bacteria_I

The O
samples O
were O
processed O
in O
order O
to O
detect O
thermotolerant O
Campylobacter Bacteria_B
spp Bacteria_I
. Bacteria_I

by O
culture O
methods O
. O

The O
positive O
samples O
were O
then O
confirmed O
by O
multiplex O
polymerase O
chain O
reaction O
. O

Thermotolerant O
Campylobacter Bacteria_B
spp Bacteria_I
. Bacteria_I

were O
isolated O
from O
118 O
( O
49 O
. O
2 O
% O
) O
of O
the O
240 O
cloacal Habitat_B
swabs Habitat_I
examined O
. O

As O
proved O
by O
PCR O
, O
100 O
% O
of O
the O
strains O
were O
identified O
as O
Campylobacter Bacteria_B
coli Bacteria_I
( O
118 O
/ O
118 O
) O
, O
and O
15 O
( O
12 O
. O
7 O
% O
) O
out O
of O
the O
118 O
positive O
samples O
were O
also O
positive O
for O
Campylobacter Bacteria_B
jejuni Bacteria_I
. O

In O
contrast O
, O
Campylobacter Bacteria_B
lari Bacteria_I
was O
not O
identified O
. O

Adult Habitat_B
partridges Habitat_I
showed O
a O
significantly O
higher O
prevalence O
( O
P O
< O
0 O
. O
05 O
) O
than O
younger Habitat_B
ones Habitat_I
. O

These O
results O
reinforce O
the O
assumption O
that O
game Habitat_B
birds Habitat_I
may O
be O
considered O
as O
potential O
carriers O
of O
Campylobacter Bacteria_B
spp Bacteria_I
. Bacteria_I

for O
human Habitat_B
being O
and O
other O
animal Habitat_B
species Habitat_I
. O

Although O
an O
earlier O
1986 O
publication O
described O
the O
prevalence O
of O
Campylobacter Bacteria_B
coli Bacteria_I
in O
commercially Habitat_B
reared Habitat_I
partridges Habitat_I
, O
this O
is O
the O
first O
report O
to O
confirm O
the O
species O
of O
Campylobacter Bacteria_B
using O
a O
PCR O
test O
. O

